ENDO Flashcards

1
Q

A 22/M presented with prognathism and increased hand and foot size. Pertinent workup showed a large pituitary adenoma on cranial CT scan with contrast. Despite undergoing transsphenoidal surgery, his IGF-I levels remain elevated. Which of the following drugs can be added next as adjuvant treatment? (HPIM C373 p2680 fig. 373-5)

a. Octreotide
b. Pegvisomant
c. Bromocriptine
d. Mitotane

A

The correct answer is: Octreotide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following characteristics about ACTH-secreting pituitary tumors best differentiate it from ectopic ACTH secretion? (HPIM C373 p2681 table 373-8)

a. 24 hour urine free cortisol is elevated
b. Cortisol is <5 ug/dL after high-dose dexamethasone suppression
c. Associated with pigmentation and rapid onset of clinical features
d. Basal inferior petrosal : peripheral vein ACTH ratio is <2

A

The correct answer is: Cortisol is <5 ug/dL after high-dose dexamethasone suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which of the following statements is true regarding non-functioning pituitary adenomas? (HPIM C373 p2682)

a. They are the most common type of pituitary adenoma.
b. They are usually microadenomas at the time of diagnosis.
c. Most clinically non-functioning adenomas originate from lactotrope cells.
d. They are responsive to treatment with dopamine agonists.

A

The correct answer is: They are the most common type of pituitary adenoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A 60/F with squamous cell lung CA stage IV is referred for an incidental finding of low serum sodium (125 mEq/L). Patient denies having nausea or vomiting. Her BP was 120/80 with clear breath sounds and no edema on PE. Which of the following strategies is best suited to correct her hyponatremia? (HPIM C374 p2690-2691)

a. Give 0.05 mL/kg/min hypertonic saline to target sodium of 130 mEq/L
b. Give 1 mL/kg/hr plain saline to target sodium of 130 mEq/L
c. Give sodium chloride 1g/tab 3x a day
d. Give tolvaptan 15 mg/tab 1x a day

A

The correct answer is: Give tolvaptan 15 mg/tab 1x a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which of the following statements is true regarding diagnostic workup for adrenal incidentalomas? (HPIM C379 p2731)

a. MRI with GAD is the procedure of choice for imaging the adrenal glands.
b. FNA or CT-guided biopsy of an adrenal mass is rarely indicated.
c. Tumor density can reliably differentiate adrenal adenomas from carcinomas
d. Tumors >4 cm are more likely malignant with a 90% specificity

A

The correct answer is: FNA or CT-guided biopsy of an adrenal mass is rarely indicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which of the following features present in primary adrenal insufficiency best distinguish it from secondary adrenal insufficiency? (HPIM C379 p2734-2735)

a. Alabaster-colored skin
b. Hyponatremia
c. Hyperreninemia
d. Low blood pressure

A

The correct answer is: Hyperreninemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which of the following enzymes is deficient in the most common form of congenital adrenal hyperplasia? (HPIM C383 p2767)

a. 21-hydroxylase
b. 17α -hydroxylase
c. 11-hydroxylase
d. 3β-hydroxysteroid dehydrogenase

A

The correct answer is: 21-hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A 28/F with previously normal menses consults for amenorrhea of 4 months duration. An extensive workup revealed no uterine tract abnormalities and negative pregnancy test. Hormone levels revealed normal prolactin and testosterone levels with increased LH and FSH levels. Which of the following is the most likely cause of her amenorrhea? (HPIM C386 p2796 fig 386-2)

a. Hypothalamic amenorrhea
b. Idiopathic hypogonadotropic hypogonadism
c. Primary ovarian insufficiency
d. Polycystic ovarian syndrome

A

The correct answer is: Primary ovarian insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

According to the Women’s Health Initiative Estrogen-Progestin and Estrogen-Alone Trials, estrogen-progestin postmenopausal hormone therapy causes a definite increase in risk in the incidence of which of the following diseases? (HPIM C388 p2805 table 388-1)

a. Coronary heart disease
b. Ovarian cancer
c. Pulmonary embolism
d. Endometrial cancer

A

The correct answer is: Pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A 40/M with T2DM and hypertriglyceridemia has a BMI of 35. What would be the best approach for the treatment of his obesity? (HPIM C395 p 2846 table 395-4)

a. Advise to decrease daily calorie intake by 750 kcal/day
b. Encourage to engage in 75 minutes/week of vigorous-intensity aerobic physical activity
c. Start phentermine/topiramate and orlistat
d. Refer for bariatric surgery

A

The correct answer is: Refer for bariatric surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which of the following statements are true regarding the criteria for the diagnosis of diabetes mellitus? (HPIM C397 p 2852 table 396-2)

a. The OGTT is the most reliable test for identifying DM in asymptomatic individuals.
b. An individual with a HbA1c of 6.5 during his first set of tests can be diagnosed with DM.
c. The current criteria allow for the diagnosis of DM to be withdrawn when glucose tolerance becomes normal.
d. Race and ethnicity have little impact in the reliability of HbA1c since it is standardized.

A

The correct answer is: The current criteria allow for the diagnosis of DM to be withdrawn when glucose tolerance becomes normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

At what age does ADA recommend initiating screening for all individuals? (HPIM C397 p2853)

a. 35
b. 40
c. 45
d. 50

A

The correct answer is: 45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which of the following best describes the genetic mechanisms behind diabetes mellitus? (HPIM C396 p2855-2856)

a. Most individuals with Type 1 DM do not have a first-degree relative with this disorder.
b. The concordance of Type 2 DM in identical twins is between 40 and 60%.
c. Type 1 DM is polygenic and multifactorial because environmental factors (e.g. obesity) also modulate the phenotype.
d. The risk of developing Type 2 DM in relatives of individuals with the disease is relatively low.

A

The correct answer is: Most individuals with Type 1 DM do not have a first-degree relative with this disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

According to ADA, which of the following drugs can be considered to prevent or delay onset of T2DM in individuals with both IFG and IGT and are at a very high risk for progression to diabetes? (HPIM C396 p2857)

a. Acarbose
b. Metformin
c. Orlistat
d. Pioglitazone

A

The correct answer is: Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the following clinical characteristics will be most consistent with a patient with new-onset Type 2 DM? (HPIM C396 p2858)

a. Elevated blood pressure
b. Propensity to develop ketoacidosis
c. Increased risk to develop autoimmune disorders
d. Lean body habitus

A

The correct answer is: Elevated blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A 36/M with Type 1 DM on insulin glargine and glulisine is an active jogger who experiences frequent episodes of light headedness during his regular routine. What would be the best advise to give him to prevent these episodes? (HPIM C397 p2861)

a. Delay jogging if blood glucose is >300 mg/dL and ketones are present.
b. Eat bread before jogging if blood glucose is <150 mg/dL.
c. Decrease insulin dose before and maintain insulin dose after jogging.
d. Inject insulin into a non-exercising area.

A

The correct answer is: Inject insulin into a non-exercising area.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which of the following statements is true regarding the properties of glycated hemoglobin? (HPIM C397 p 2862).

a. It detects glycemic variability like self-monitoring of blood glucose
b. Glycemic level in the preceding month contributes about 70% to the HbA1c value.
c. Recent intercurrent illnesses can impact HbA1c.
d. Nocturnal hyperglycemia will be reflected in the HbA1c.

A

The correct answer is: Nocturnal hyperglycemia will be reflected in the HbA1c.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which of the following statements most accurately reflect frequently used insulin regimens in Type 1 DM? (HPIM C397 p 2864).

a. In general, Type 1 DM patients require 1-2 units/kg per day of insulin.
b. A common insulin-to-carbohydrate ratio is 1 unit per 15 g of carbohydrate.
c. Insulin is given as multiple doses with 70% given as basal insulin.
d. Supplemental insulin is given at 2 units of insulin for every 50 mg/dL over glucose target.

A

The correct answer is: A common insulin-to-carbohydrate ratio is 1 unit per 15 g of carbohydrate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A 70/F with T2DM on metformin complains of frequent nausea, diarrhea and anorexia. Since she is not able to eat properly, she has intermittent episodes of light headedness and blurring of vision. Her current HBA1c is 8.5. Which of the following glucose-lowering agents is best suited for her in place of metformin? (HPIM C397 p 2866 table 397-5)

a. Dapagliflozin
b. Miglitol
c. Repaglinide
d. Glimepiride

A

The correct answer is: Dapagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A 45/F with Type 2 DM has been taking Metformin 500 mg BID for the past 3 years. Her latest HbA1c is 9.0 and her BMI has been steadily increasing, now at 32. What add-on glucose-lowering agent will benefit her the most? (HPIM C397 p 2866 table 397-5)

a. Pioglitazone
b. Gliclazide
c. Dulaglutide
d. Glargine

A

The correct answer is: Dulaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which of the following T2DM patients will benefit the most in the initiation of insulin therapy? (HPIM C397 p 2868)

a. 40/M with waist circumference of 95 cm
b. 45/F with HbA1c of 8.0 on metformin monotherapy
c. 50/M with FBS of 190 mg/dL not yet on any meds
d. 55/F with tuberculosis-related cachexia

A

The correct answer is: 55/F with tuberculosis-related cachexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

A 50/M with T2DM was rushed in the ER due to severe abdominal pain and vomiting. Blood glucose was 300 mg/dL with an arterial pH of 7.2 and a serum bicarbonate of 12 mEq/L. Serum creatine was 250 mmol/L, sodium was 122, chloride was 79 and potassium was 3.0 mEq/L. Which of the following management measures is the most appropriate for the patient’s condition? (HPIM C397 p2871 table 397-8).

a. Administer short-acting regular insulin IV (0.1 units/kg) bolus then 0.1 units/kg/hr by infusion.
b. Give 150 mEqs sodium bicarbonate bolus then give additional 250 mEqs by infusion over 24 hours.
c. Measure electrolytes and anion gap every 4 hours for first 24 hours.
d. Run 2-3 L of 0.45% saline at 10-20 mL/kg/hr over the first 1-3 hours.

A

The correct answer is: Measure electrolytes and anion gap every 4 hours for first 24 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which of the following statements best describe hyperglycemic hyperosmolar state? (HPIM C397 p2872)

a. HHS has a higher mortality rate than DKA
b. HHS patients are usually younger than DKA patients
c. Fluid losses are less pronounced in HHS compared to in DKA
d. Mental status changes are less seen in HHS compared to in DKA

A

The correct answer is: HHS has a higher mortality rate than DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

A 56/M with T2DM was admitted in the ICU due to acute respiratory failure from hospital acquired pneumonia. His CBGs have been ranging from 200 – 300 mg/dL. Which of the following glycemic-lowering agents is most appropriate for him? (HPIM C397 p2873)

a. Insulin glulisine as subcutaneous boluses
b. Regular insulin as intravenous infusion
c. Insulin apidra as intravenous boluses
d. Insulin glargine as single subcutaneous bolus

A

The correct answer is: Regular insulin as intravenous infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

A 42/F with T2DM with a BMI of 30 was admitted in the hospital due to acute pyelonephritis. She is currently afebrile with BP of 120/80. She is currently on insulin glargine 6 units SC injected at night and regular insulin 6 units pre-meals. Her current pre-lunch CBG is 280 mg/dL. Based on ADA recommendations, which of the following regimens will best address her hyperglycemia immediately? (HPIM C397 p2873)

a. Increase insulin glargine to 8 units pre-bedtime
b. Give regular insulin 8 units SC pre-lunch
c. Add insulin glargine 10 units pre-breakfast
d. Give regular insulin 10 units SC pre-lunch

A

The correct answer is: Give regular insulin 10 units SC pre-lunch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

A 28/M with T1DM and choledocholithiasis is about to undergo open cholecystectomy. Which of the following insulin regimens is the LEAST sufficient to address his glycemic control? (HPIM C397 p2874)

a. Regular insulin via insulin pump
b. Regular insulin via IV infusion
c. Regular insulin via multiple SC boluses
d. Insulin detemir via single dose SC

A

The correct answer is: Regular insulin via multiple SC boluses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

According to current recommendations, screening for gestational diabetes mellitus occurs during between what ages of gestation? (HPIM C397 p2874)

a. 12 and 16 weeks
b. 16 and 20 weeks
c. 20 and 24 weeks
d. 24 and 28 weeks

A

The correct answer is: 24 and 28 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Which of the following statements is consistent with the findings of the DCCT and UKPDS with regards to glycemic control and the development of DM complications? (HPIM C398 p2875-2876)

a. There is strong evidence that chronic hyperglycemia leads to micro- and macrovascular complications.
b. There is a positive impact of a period of improved glycemic control on later disease.
c. The beneficial effects of glycemic control were greater than the beneficial effects of BP control.
d. The benefits of improvement in glycemic control were seen at HbA1c levels ≥ 9%

A

The correct answer is: There is a positive impact of a period of improved glycemic control on later disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

A 45/M newly diagnosed with T2DM had his 1st positive urinary albumin test. Which of the following is the most appropriate action to take in managing his diabetic nephropathy? (HPIM C398 p2878 fig 398-4)

a. Repeat albuminuria test after 3 months.
b. Repeat albuminuria test after 12 months.
c. Begin treatment of nephropathy immediately.
d. Begin treatment of nephropathy once he has 3 positive albuminuria tests.

A

The correct answer is: Repeat albuminuria test after 3 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Which of the following statements best describe the most common form of diabetic neuropathy? (HPIM C398 p2879)

a. Pain involves the lower extremities, is usually absent at rest and worsens at night.
b. There is hyperhidrosis of the upper extremities and anhidrosis of the lower extremities.
c. Involvement of the third cranial nerve is most common and is heralded by diplopia.
d. There is loss of ankle deep-tendon reflexes and foot drop.

A

The correct answer is: There is loss of ankle deep-tendon reflexes and foot drop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the most common pattern of dyslipidemia seen in diabetes mellitus? (HPIM C398 p2881)

a. High triglyceride, normal HDL, high LDL
b. High triglyceride, low HDL, normal LDL
c. Normal triglyceride, low HDL, high LDL
d. Normal triglyceride, normal HDL, high LDL

A

The correct answer is: High triglyceride, low HDL, normal LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

A 33/M known diabetic was rushed into the ER due to 4-day history of fever associated with severe pain, foul-smelling discharge and hearing loss on her right ear. Which of the following organisms is the most common etiologic agent for her condition? (HPIM C398 p2882)

a. Candida albicans
b. Staphylococcus epidermidis
c. Pseudomonas aeruginosa
d. Staphylococcus aureus

A

The correct answer is: Pseudomonas aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

A 45/M T2DM patient complained of frequent light headedness, diaphoresis and palpitations. His CBGs ranges from 45-80 mg/dL/ His workup revealed a 1.0 cm pancreatic head mass on abdominal CT scan. Which of the following pathophysiologic features best explain his symptoms in correlation with his disease? (HPIM C399 p2887)

a. Failure of insulin secretion to fall during hypoglycemia
b. Overproduction of an incomplete form of insulin growth factor II
c. Impaired gluconeogenesis and low gluconeogenic precursors
d. Combined deficiency of glucagon and epinephrine

A

The correct answer is: Failure of insulin secretion to fall during hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

A 20/M presents in the ER due to a 2 day-history of severe abdominal pain and vomiting. Pertinent lab findings include a markedly elevated triglyceride level at 1000 mg/dL with slightly elevated LDL and cholesterol levels. Physical exam revealed small, yellowish-white papules on the back. Which of the following conditions does the patient most likely has? (HPIM C400 p2894)

a. Familial Combined Hyperlipidemia
b. Familal Dysbetalipoproteineima
c. Familial Hypercholesterolemia
d. Familial Chylomicronemia

A

The correct answer is: Familial Chylomicronemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

It is important to intervene in patients with fasting triglyceride levels of >500 mg/dL in order to reduce the risk of developing what particular disease? (HPIM C400 p2901)

a. Acute stroke
b. Acute myocardial infarction
c. Acute pancreatitis
d. Acute ischemic hepatitis

A

The correct answer is: Acute pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is the drug of choice for a diabetic 30/F presenting with a triglyceride level of 600 mg/dL despite active lifestyle management? (HPIM C400 p2901)

a. Atorvastatin
b. Cholestyramine
c. Ezetemibe
d. Omega-3 FA

A

The correct answer is: Omega-3 FA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

The most common pituitary hormone-secreting adenoma originates from which of the following anterior pituitary cell? (HPIM C373 P2674 table 373-3)

a. Corticotrope
b. Gonadotrope
c. Lactotrope
d. Somatotrope

A

In DECREASING ORDER of frequency

Hyperprolactinemia is the most common pituitary hormone hypersecretion syndrome in both men and women

The correct answer is: Lactotrope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

A 22/M presented with prognathism and increased hand and foot size. Pertinent workup showed a large pituitary adenoma on cranial CT scan with contrast. Despite undergoing transsphenoidal surgery, his IGF-I levels remain elevated. Which of the following drugs can be added next as adjuvant treatment? (HPIM C373 p2680 fig. 373-5)

a. Octreotide
b. Pegvisomant
c. Bromocriptine
d. Mitotane

A

Patient has classic signs of ACROMEGALY

Somatostatin analogues are used as adjuvant treatment for:
• preoperative shrinkage of large invasive macroadenomas
• immediate relief of debilitating symptoms and reduction of GH hypersecretion
• in frail patients experiencing morbidity
• in patients who decline surgery
• when surgery fails

The correct answer is: Octreotide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Which of the following characteristics about ACTH-secreting pituitary tumors best differentiate it from ectopic ACTH secretion? (HPIM C373 p2681 table 373-8)

a. 24 hour urine free cortisol is elevated
b. Cortisol is <5 ug/dL after high-dose dexamethasone suppression
c. Associated with pigmentation and rapid onset of clinical features
d. Basal inferior petrosal : peripheral vein ACTH ratio is <2

A

24 hr urine free cortisol is elevated in both

High dose Dexa suppression test will be able to inhibit cortisol production in ACTH-dependent pituitary tumors via the feedback mechanism but has NO EFFECT on ECTOPIC ACTH sources

Rapid onset of symptoms and pigmentation are associated with ECTOPIC ACTH secretion

Basal inferior petrosal : peripheral vein ACTH ratio of <2 is consistent with ECTOPIC ACTH secretion

The correct answer is: Cortisol is <5 ug/dL after high-dose dexamethasone suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Prophylactic radiation therapy may be indicated to prevent the development of what syndrome after adrenalectomy in the setting of residual corticotrope adenoma? (HPIM C373 p2682)

a. Albright syndrome
b. Kallmann syndrome
c. Nelson syndrome
d. Wolfram syndrome

A

NELSON’S SYNDROME
A disorder characterized by rapid pituitary tumor enlargement and increased pigmentation secondary to high ACTH levels.

Prophylactic radiation therapy may be indicated to prevent the development of Nelson’s syndrome after adrenalectomy.

The correct answer is: Nelson syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Which of the following statements is true regarding non-functioning pituitary adenomas? (HPIM C373 p2682)

a. They are the most common type of pituitary adenoma.
b. They are usually microadenomas at the time of diagnosis.
c. Most clinically non-functioning adenomas originate from lactotrope cells.
d. They are responsive to treatment with dopamine agonists.

A

NON-FUNCTIONING PITUITARY ADENOMAS
They are the most common type of pituitary adenomas

They are usually MACROADENOMAS at the time of diagnosis because clinical features are not apparent until mass effect occurs

Based on immunohistochemistry, most clinically nonfunctioning adenomas can be shown to originate from gonadotrope cells.

It is important to distinguish this circumstance from true prolactinomas, as nonfunctioning tumors do not shrink in response to treatment with dopamine agonists

The correct answer is: They are the most common type of pituitary adenoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Which of the following DOES NOT stimulate Vasopressin (AVP) secretion from the neurohypophysis? (HPIM C374 p2684)

a. Smoking
b. Hypotension
c. Nausea
d. Pain

A
VASOPRESSIN SECRETION
Can be stimulated by the ff:
•	Hyperosmolarity (280 mosm/L)
•	Hypotension (10-20% decrease in BP)
•	Nausea (very potent – can cause 50-100 fold rise in AVP)
•	Acute hypoglycemia
•	Glucocorticoid deficiency
•	Smoking

There is no evidence that pain or other noxious stresses have any effect on AVP unless they elicit a vasovagal reaction with its associated nausea and hypotension

The correct answer is: Pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

A 30/M patient presents in the ICU with progressive decrease in sensorium. He underwent cranial surgery for head trauma 2 days prior. Pertinent workup revealed a serum sodium of 168 mmol/L. Average 24 hour urine output for the past 2 days was 4000 mL. Which of the following findings will best point to his likely diagnosis? (HPIM C374 p2687 fig 374-4)

a. Urine osmolarity of <300 mosm/L
b. Plasma AVP <1 pg/mL
c. No pituitary bright spot on MRI
d. Plasma osmolarity of >300 mosm/L

A

Acute hypernatremia and increased volume of urine in the setting of post-cranial surgery is highly suggestive of post-op pituitary diabetes insipidus

Urine osmolarity of <300 mosm/L is present in pituitary DI, primary polydipsia and nephrogenic DI

Plasma AVP <1 pg/mL is present in both primary polydipsia and pituitary DI

The pituitary bright spot is almost always absent or abnormally small in patients with pituitary DI

Plasma osmolarity of >300 can be present in both DI and non-DI etiologies

The correct answer is: No pituitary bright spot on MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

A 60/F with squamous cell lung CA stage IV is referred for an incidental finding of low serum sodium (125 mEq/L). Patient denies having nausea or vomiting. Her BP was 120/80 with clear breath sounds and no edema on PE. Which of the following strategies is best suited to correct her hyponatremia? (HPIM C374 p2690-2691)

a. Give 0.05 mL/kg/min hypertonic saline to target sodium of 130 mEq/L
b. Give 1 mL/kg/hr plain saline to target sodium of 130 mEq/L
c. Give sodium chloride 1g/tab 3x a day
d. Give tolvaptan 15 mg/tab 1x a day

A

HYPONATREMIA TREATMENT
Patient most likely has Chronic Hyponatremia secondary to SIADH from lung CA

Patient is euvolemic and asymptomatic

Hyponatremia in this case should be corrected more gradually to avoid osmotic demyelination syndrome

This can be achieved by restricting total fluid intake to less than the sum of urinary and insensible losses. This regimen is often hard to adhere to.

It is often necessary to add a treatment that increases urinary water excretion. The oral AVP2 antagonist, tolvaptan, is best suited for this purpose.

The correct answer is: Give tolvaptan 15 mg/tab 1x a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Which of the following is a specific feature of Cushing’s syndrome? (HPIM C379 p2725)

a. Buffalo hump
b. Proximal myopathy
c. Facial plethora
d. Hirsutism

A

A diagnosis of Cushing’s should be considered when several clinical features are found in the same patient, in particular when
more specific features are found. These include

  • fragility of the skin, with easy bruising
  • broad (>1 cm), purplish striae
  • signs of proximal myopathy, which becomes most obvious when trying to stand up from a chair without the use of hands or when climbing stairs

The correct answer is: Proximal myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

A 35/M presents with consistent home BPs of 160-170/100-110 despite compliance with telmisartan. Pertinent labs revealed a serum potassium of 3.0 mEq/L. Which of the following is the most practical strategy to observe in preparation for further workup for the cause of his hypertension? (HPIM C379 p2729-2730 table 379-4)

a. Order for plasma renin and aldosterone levels right away
b. Stop telmisartan at least 2 weeks prior to ARR measurement
c. Stop telmisartan and shift to carvedilol 4 weeks prior to ARR measurement
d. Continue telmisartan and correct hypokalemia prior to ARR measurement

A

DIAGNOSTIC SCREENING FOR MINERALOCORTICOID EXCESS
The accepted screening test is concurrent measurement of plasma renin and aldosterone with subsequent calculation of the aldosterone-renin ratio (ARR)

Serum potassium should be normalized prior to testing

Stopping antihypertensive medication can be cumbersome, particularly in patients with severe hypertension.

For practical purposes, in the first instance the patient can remain on the usual antihypertensive medications, with the exception that MR antagonists need to be ceased at least 4 weeks prior to ARR measurement.

Carvedilol can falsely increase ARR

The correct answer is: Continue telmisartan and correct hypokalemia prior to ARR measurement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which of the following statements is true regarding diagnostic workup for adrenal incidentalomas? (HPIM C379 p2731)

a. MRI with GAD is the procedure of choice for imaging the adrenal glands.
b. FNA or CT-guided biopsy of an adrenal mass is rarely indicated.
c. Tumor density can reliably differentiate adrenal adenomas from carcinomas
d. Tumors >4 cm are more likely malignant with a 90% specificity

A

DIAGNOSIS OF INCIDENTALOMAS
Unenhanced CT is the procedure of choice for imaging the adrenal glands

Size alone is of poor predictive value, with only 80% sensitivity and 60% specificity for the differentiation of benign from malignant masses when using a 4-cm cut-off

Tumor density on CT is of additional diagnostic value as many adrenocortical adenomas have low attenuation values. However, many of them also present with higher HU

FNA or CT-guided biopsy of an adrenal mass is rarely indicated
• FNA of pheochromocytoma can cause hypertensive crisis
• FNA of adrenocortical carcinoma can cause needle track metastasis
• Should only be considered in a patient with nonadrenal malignancy and a newly detected adrenal mass, after ruling out pheochromocytoma and if the outcome will influence therapeutic management

The correct answer is: FNA or CT-guided biopsy of an adrenal mass is rarely indicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Which of the following is the most common cause of primary adrenal insufficiency? (HPIM C379 p2733)

a. Autoimmune adrenalitis
b. Adrenal hemorrhage
c. Congenital adrenal hyperplasia
d. Tuberculous adrenalitis

A

PRIMARY ADRENAL INSUFFICIENCY
Primary adrenal insufficiency is most commonly caused by autoimmune adrenalitis.

Isolated autoimmune adrenalitis accounts for 30–40%, whereas 60–70% develop adrenal insufficiency as part of autoimmune polyglandular syndromes (APSs)

Rarer causes of adrenal insufficiency involve destruction of the adrenal glands as a consequence of infection, hemorrhage, or infiltration.

Tuberculous adrenalitis is still a frequent cause of disease in developing countries.
The correct answer is: Autoimmune adrenalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Which of the following features present in primary adrenal insufficiency best distinguish it from secondary adrenal insufficiency? (HPIM C379 p2734-2735)

a. Alabaster-colored skin
b. Hyponatremia
c. Hyperreninemia
d. Low blood pressure

A

PRIMARY ADRENAL INSUFFICIENCY
Characterized by the loss of both glucocorticoid and mineralocorticoid secretion

A distinguishing feature of primary adrenal insufficiency is hyperpigmentation, which is caused by excess ACTH stimulation of
melanocytes.

Hyponatremia can be present in both mineralocorticoid deficiency and in secondary adrenal insufficiency due to diminished inhibition of ADH release by cortisol.

Increased plasma renin will confirm presence of mineralocorticoid deficiency

Low BP and postural hypotension can be present in both

The correct answer is: Hyperreninemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

A 20-year old patient is referred at the OPD due to gynecomastia. Physical assessment revealed a male appearance with tall stature and small testes. Hormonal workup revealed elevated LH, FSH and estradiol and low testosterone levels. Semen analysis reveals azoospermia. Which of the following is the patient’s most likely chromosomal sex? (HPIM C383 p2762-2763 table 383-3)

a. 45,X/46,XX
b. 45,X/46,XY
c. 46,XX/46,XY
d. 46,XY/47,XXY

A

The correct answer is: 46,XY/47,XXY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Which of the following enzymes is deficient in the most common form of congenital adrenal hyperplasia? (HPIM C383 p2767)

a. 21-hydroxylase
b. 17α -hydroxylase
c. 11-hydroxylase
d. 3β-hydroxysteroid dehydrogenase

A

CONGENITAL ADRENAL HYPERPLASIA
The classic form of 21-hydroxylase deficiency (21-OHD) is the most common cause of CAH

The salt-wasting form of 21-OHD results from severe combined glucocorticoid and mineralocorticoid deficiency.

Females with classic simple virilizing form of 21-OHD present with genital ambiguity. They have impaired cortisol biosynthesis but do not have salt loss.

Patients with non-classic 21-OHD produce normal amounts of cortisol and aldosterone but at the expense of producing excess androgens.

The correct answer is: 21-hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Which of the following hormones is necessary for the masculinization of the urogenital sinus and genital tubercle? (HPIM C384 p2772)

a. 5α dihydrotestosterone
b. Androsterone
c. Androstanedione
d. Testosterone

A

The conversion of testosterone to DHT is necessary for the masculinization of the urogenital sinus and genital tubercle.

The correct answer is: 5α dihydrotestosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

A 28/F with previously normal menses consults for amenorrhea of 4 months duration. An extensive workup revealed no uterine tract abnormalities and negative pregnancy test. Hormone levels revealed normal prolactin and testosterone levels with increased LH and FSH levels. Which of the following is the most likely cause of her amenorrhea? (HPIM C386 p2796 fig 386-2)

a. Hypothalamic amenorrhea
b. Idiopathic hypogonadotropic hypogonadism
c. Primary ovarian insufficiency
d. Polycystic ovarian syndrome

A

The correct answer is: Primary ovarian insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

According to the Women’s Health Initiative Estrogen-Progestin and Estrogen-Alone Trials, estrogen-progestin postmenopausal hormone therapy causes a definite increase in risk in the incidence of which of the following diseases? (HPIM C388 p2805 table 388-1)

a. Coronary heart disease
b. Ovarian cancer
c. Pulmonary embolism
d. Endometrial cancer

A

The correct answer is: Pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Which of the following is an absolute contraindication to starting oral contraceptives? (HPIM C388 p2815 table 389-2)

a. Post-bariatric surgery
b. Controlled Hypertension
c. Women receiving anticonvulsant therapy
d. Systemic Lupus Erythematosus

A

The correct answer is: Systemic Lupus Erythematosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Which of the following best describes very low-calorie diets (VLCDs)? (HPIM C395 p 2845)

a. It typically supplies ≤800 kcal per day with 50-80 g of protein
b. It is indicated for well-motivated individuals with a BMI of ≥25 kg/m2 who have failed at more conservative approaches to weight loss.
c. Its primary purpose is to promote a significant weight loss over a 6- to 12-month period.
d. It can lead to increased risk of gallstone formation that is not reduced with ursodeoxycholic acid prophylaxis.

A

VERY LOW-CALORIE DIETS (VLCDs)
The primary purpose of a VLCD is to promote a rapid and significant (13- to 23-kg) short-term weight loss over a 3- to 6-month period.

The proprietary formulas designed for this purpose typically supply ≤800 kcal, 50–80 g of protein, and 100% of the recommended daily intake for vitamins and minerals

indications include the involvement of well-motivated individuals who are
• moderately to severely obese (BMI, >30 kg/m2)
• have failed at more conservative approaches to weight loss
• have a medical condition that would be immediately improved with rapid weight loss
The risk of gallstone formation increases exponentially at rates of weight loss >1.5 kg/week

Prophylaxis against gallstone formation with UDCA 600 mg/d is effective in reducing this risk.
The correct answer is: It typically supplies ≤800 kcal per day with 50-80 g of protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

A 40/M with T2DM and hypertriglyceridemia has a BMI of 35. What would be the best approach for the treatment of his obesity? (HPIM C395 p 2846 table 395-4)

a. Advise to decrease daily calorie intake by 750 kcal/day
b. Encourage to engage in 75 minutes/week of vigorous-intensity aerobic physical activity
c. Start phentermine/topiramate and orlistat
d. Refer for bariatric surgery

A

Bariatric surgery can be considered for patients with
• severe obesity (BMI, ≥40 kg/m2) OR
• for those with moderate obesity (BMI, ≥35 kg/m2) associated with a serious medical condition

The correct answer is: Refer for bariatric surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Which of the following statements is true regarding the criteria for the diagnosis of diabetes mellitus? (HPIM C397 p 2852 table 396-2)

a. The OGTT is the most reliable test for identifying DM in asymptomatic individuals.
b. An individual with a HbA1c of 6.5 during his first set of tests is diagnostic of DM.
c. The current criteria allow for the diagnosis of DM to be withdrawn when glucose tolerance becomes normal.
d. Race and ethnicity have little impact in the reliability of HbA1c since it is standardized.

A

The current criteria for the diagnosis of DM emphasize the HbA1c or the FPG as the most reliable and convenient tests for identifying DM in asymptomatic individuals.

An OGTT, although a valid means for diagnosing DM, is not often used in routine clinical care with the exception of pregnancy care and screening for gestational diabetes.

Abnormalities on screening tests for diabetes should be repeated before making a definitive diagnosis of DM, unless acute metabolic derangements or a markedly elevated plasma glucose are present

These criteria also allow for the diagnosis of DM to be withdrawn in situations when the glucose intolerance reverts to normal

It is important to note that race and ethnicity may impact the reliability of HbA1c levels. For example, African Americans have a higher HbA1c value compared to non-Hispanic whites with a similar level of glycemia.

The correct answer is: The current criteria allow for the diagnosis of DM to be withdrawn when glucose tolerance becomes normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

At what age does ADA recommend initiating screening for all individuals? (HPIM C397 p2853)

a. 35
b. 40
c. 45
d. 50

A

ADA RECOMMENDATIONS FOR SCREENING
The ADA recommends screening all individuals aged >45 years every 3 years and screening individuals at an earlier age if they are overweight (BMI >25 kg/m2 or ethnically relevant definition for overweight) and have one additional risk factor for diabetes

The correct answer is: 45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

A 30/F has a BMI of 27 kg/m2. Which among the following findings in the patient will prompt screening for Type 2 DM? (HPIM C397 p2853 table 396-3)

a. Hemoglobin A1c of 5.5%
b. Blood pressure of 140/90
c. 2 hour post prandial glucose of 130 mg/dL
d. Triglyceride level of 200 mg/dL

A

ADA RECOMMENDATIONS FOR SCREENING
The ADA recommends screening all individuals aged >45 years every 3 years and screening individuals at an earlier age if they are overweight (BMI >25 kg/m2 or ethnically relevant definition for overweight) and have one additional risk factor for diabetes

The correct answer is: Blood pressure of 140/90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Which of the following best describes the genetic mechanisms behind diabetes mellitus? (HPIM C396 p2855-2856)

a. Most individuals with Type 1 DM do not have a first-degree relative with this disorder.
b. The concordance of Type 2 DM in identical twins is between 40 and 60%.
c. Type 1 DM is polygenic and multifactorial because environmental factors (e.g. obesity) also modulate the phenotype.
d. The risk of developing Type 2 DM in relatives of individuals with the disease is relatively low.

A

GENETIC CONSIDERATIONS OF DM
Although the risk of developing type 1 DM is increased tenfold in relatives of individuals with the disease, the risk is relatively low: 3–4% if the parent has type 1 DM and 5–15% in a sibling .

Hence, most individuals with type 1 DM (75%) do not have a first-degree relative with this disorder

Type 2 DM has a strong genetic component. The concordance of type 2 DM in identical twins is between 70 and 90%

Individuals with a parent with type 2 DM have an increased risk of diabetes; if both parents have type 2 DM, the risk approaches 40%

Type 2 DM is polygenic and multifactorial, because in addition to genetic susceptibility, environmental factors (such as obesity, poor nutrition, and physical inactivity) modulate the phenotype
The correct answer is: Most individuals with Type 1 DM do not have a first-degree relative with this disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

According to ADA, which of the following drugs can be considered to prevent or delay onset of T2DM in individuals with both IFG and IGT and are at a very high risk for progression to diabetes? (HPIM C396 p2857)

a. Acarbose
b. Metformin
c. Orlistat
d. Pioglitazone

A

DM PREVENTION
A number of agents, including a-glucosidase inhibitors, metformin, thiazolidinediones, GLP-1 receptor pathway modifiers, and orlistat, prevent or delay type 2 DM but are not approved by the Food and Drug Administration for this purpose.

Pharmacologic therapy for individuals with prediabetes is currently controversial because its cost-effectiveness and safety profile are not known.

The ADA suggests that metformin be considered in individuals with both IFG and IGT who are at very high risk for progression to diabetes (age <60 years, BMI ≥35 kg/m2, and women with a history of GDM)

The correct answer is: Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Which of the following monogenic forms of DM will respond well to sulfonylurea treatment? (HPIM C396 p2858)

a. MODY 1
b. MODY 2
c. MODY 3
d. MODY 4

A

MONOGENIC FORMS OF DM
MODY 1, MODY 3, and MODY 5 are caused by mutations in hepatocyte nuclear transcription factor (HNF) 4a, HNF-1a, and HNF-1B, respectively.

Individuals with an HNF-1a mutation (MODY 3) have a progressive decline in glycemic control but may respond to sulfonylureas.

Individuals with MODY 2, the result of mutations in the glucokinase gene, have mild-to-moderate, but stable hyperglycemia that does not respond to oral hypoglycemic agents

MODY 4 is a rare variant caused by mutations in pancreatic and duodenal homeobox 1, a transcription factor that regulates pancreatic development and insulin gene transcription

The correct answer is: MODY 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Which of the following clinical characteristics will be most consistent with a patient with new-onset Type 2 DM? (HPIM C396 p2858)

a. Elevated blood pressure
b. Propensity to develop ketoacidosis
c. Increased risk to develop autoimmune disorders
d. Lean body habitus

A

The correct answer is: Elevated blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Which of the following screening procedures is part of the guidelines for comprehensive diabetes care for all individuals with DM? (HPIM C397 p2860 table 397-1)

a. Lipid profile testing every 6 months
b. Urine albumin testing every 4 months
c. Blood pressure assessment every 3 months
d. Foot examination by the patient monthly

A

Lipids annually
Diabetes-related kidney disease testing annually
Blood pressure assessment quarterly

Foot examination
• 1-2 times/year by provider
• Daily by patient

The correct answer is: Blood pressure assessment every 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

A 36/M with Type 1 DM on insulin glargine and glulisine is an active jogger who experiences frequent episodes of light headedness during his regular routine. What would be the best advise to give him to prevent these episodes? (HPIM C397 p2861)

a. Delay jogging if blood glucose is >300 mg/dL and ketones are present.
b. Eat bread before jogging if blood glucose is <150 mg/dL.
c. Decrease insulin dose before and maintain insulin dose after jogging.
d. Inject insulin into a non-exercising area.

A

AVOIDANCE OF EXERCISE-RELATED HYPO/HYPERGLYCEMIA
• monitor blood glucose before, during, and after exercise
• delay exercise if blood glucose is >14 mmol/L (250 mg/dL) and ketones are present
• If the blood glucose is <5.6 mmol/L (100 mg/dL), ingest carbohydrate before exercising
• Monitor glucose during exercise and ingest carbohydrate to prevent hypoglycemia
• Decrease insulin doses (based on previous experience) before and after exercise and inject insulin into a non-exercising area
• Learn individual glucose responses to different types of exercise

The correct answer is: Inject insulin into a non-exercising area.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Which of the following statements is true regarding the properties of glycated hemoglobin? (HPIM C397 p 2862).

a. It detects glycemic variability like self-monitoring of blood glucose
b. Glycemic level in the preceding month contributes about 70% to the HbA1c value.
c. Recent intercurrent illnesses can impact HbA1c.
d. Nocturnal hyperglycemia will be reflected in the HbA1c.

A

ASSESSMENT OF LONG TERM GLYCEMIC CONTROL
Measurement of glycated hemoglobin (HbA1c) is the standard method for assessing long-term glycemic control.

Glycemic level in the preceding month contributes about 50% to the HbA1c value

As the primary predictor of long-term complications of DM, the HbA1c should mirror, to a certain extent, the short-term measurements of SMBG

These two measurements are complementary in that recent intercurrent illnesses may impact the SMBG measurements but not the HbA1c

Likewise, postprandial and nocturnal hyperglycemia may not be detected by the SMBG of fasting and preprandial capillary plasma glucose but will be reflected in the HbA1c

The HbA1c is an “average” and thus does not detect glycemic variability in the way SMBG and CGM can.

The correct answer is: Nocturnal hyperglycemia will be reflected in the HbA1c.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Which of the following statements most accurately reflect frequently used insulin regimens in Type 1 DM? (HPIM C397 p 2864).

a. In general, Type 1 DM patients require 1-2 units/kg per day of insulin.
b. A common insulin-to-carbohydrate ratio is 1 unit per 15 g of carbohydrate.
c. Insulin is given as multiple doses with 70% given as basal insulin.
d. Supplemental insulin is given at 2 units of insulin for every 50 mg/dL over glucose target.

A

TYPE 1 DM INSULIN REGIMENS
In general, individuals with type 1 DM require 0.4–1 units/kg per day of insulin divided into multiple doses, with ~50% of the insulin given as basal insulin

To determine the meal component of the preprandial insulin dose, the patient uses an insulin-to carbohydrate ratio
• a common ratio for type 1 DM is 1 unit/10–15 g of carbohydrate, but this must be determined for each individual
To this insulin, dose is added the supplemental or correcting insulin based on the preprandial blood glucose (one formula uses 1 unit of insulin for every 2.7 mmol/L [50 mg/dL] over the preprandial glucose target

An alternative multiple-component insulin regimen consists of bedtime NPH insulin, a small dose of NPH insulin at breakfast (20–30% of bedtime dose), and preprandial short-acting insulin

The correct answer is: A common insulin-to-carbohydrate ratio is 1 unit per 15 g of carbohydrate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

A 50/F with newly diagnosed T2DM and CHF was initially prescribed with metformin and was advised medical nutrition therapy. After 3 months, her repeat labs showed an increase in HBA1c from 8.5 to 9.0. Her eGFR decreased from 50 mL/min to 35 mL/min. After reducing her metformin dose, which of the following is the most suitable drug to be added to her current regimen? (HPIM C397 p2866-2869)

a. Empagliflozin
b. Glargine
c. Pioglitazone
d. Vildagliptin

A

Patient has rise in HbA1c on metformin monotherapy as well as reduction in eGFR

Next step is to add a second agent, usually an oral antihyperglycemic in combination with metformin

Patient can still use metformin but in reduced dose (eGFR <35)

Empagliflozin cannot be initiated at eGFR <45

Glargine can be added only if dual OHAs cannot control HbA1c after next reassessment

Pioglitazone is contraindicated in this patient due to her CHF

Vildagliptin is the best choice because it can be given without renal dose adjustment
The correct answer is: Vildagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

A 70/F with T2DM on metformin complains of frequent nausea, diarrhea and anorexia. Since she is not able to eat properly, she has intermittent episodes of light headedness and blurring of vision. Her current HBA1c is 8.5. Which of the following glucose-lowering agents is best suited for her in place of metformin? (HPIM C397 p 2866 table 397-5)

a. Dapagliflozin
b. Miglitol
c. Repaglinide
d. Glimepiride

A

Patient cannot tolerate Metformin (nausea and vomiting) and has hypoglycemic episodes

Miglitol and repaglinide are nonsulfonylurea secretagogues, while glimepiride is a sulfonylurea. All of them can cause hypoglycemia which the patient is already having due to poor appetite

SGLT2 inhibitors like dapagliflozin do not cause hypoglycemia and is best suited for our patient among the choices

The correct answer is: Dapagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

A 45/F with Type 2 DM has been taking Metformin 500 mg BID for the past 3 years. Her latest HbA1c is 9.0 and her BMI has been steadily increasing, now at 32. What add-on glucose-lowering agent will benefit her the most? (HPIM C397 p 2866 table 397-5)

a. Pioglitazone
b. Gliclazide
c. Dulaglutide
d. Glargine

A

Patient has uncontrolled DM on Metformin therapy and is steadily gaining weight (increase in BMI)

Pioglitazone, gliclazide and glargine all cause weight gain due to effects of insulin

GLP-1 receptor agonists like dulaglutide cause weight loss that can benefit obese patients

The correct answer is: Dulaglutide

72
Q

A 56/M with known T2DM was admitted in the ICU due to fever and difficulty of breathing. Workup revealed blood glucose of 180 mg/dL with an arterial pH of 7.15 and a serum bicarbonate of 10. Anion gap was 22 with urine ketones of 3+. What glucose-lowering agent that the patient was taking could have caused this condition? (HPIM C397 p 2868)

a. Canagliflozin
b. Glyburide
c. Linagliptin
d. Metformin

A

SGLT2 INHIBITOR INDUCED EUGLYCEMIC DKA
Inhibition of SGLT2 on the alpha cell may lead to increased glucagon and consequently liver production of glucose and ketones

Euglycemic DKA presents with metabolic acidosis and ketone formation in the background of only a slightly elevated glucose levels (<250 mg/dL)

Euglycemic DKA may occur during illness or when ongoing glucosuria masks stress-induced requirements for insulin.
These agents should not be prescribed for patients with type 1 DM or pancreatogenic forms of DM associated with insulin deficiency

The correct answer is: Canagliflozin

73
Q

Which of the following T2DM patients will benefit the most in the initiation of insulin therapy? (HPIM C397 p 2868)

a. 40/M with waist circumference of 95 cm
b. 45/F with HbA1c of 8.0 on metformin monotherapy
c. 50/M with FBS of 190 mg/dL not yet on any meds
d. 55/F with tuberculosis-related cachexia

A

INSULIN THERAPY IN TYPE 2 DM
Insulin should be considered as part of the initial therapy in type 2 DM, particularly in:
• lean individuals
• those with severe weight loss
• in individuals with underlying renal or hepatic disease that precludes oral glucose-lowering agents
• In individuals who are hospitalized or acutely ill.

The correct answer is: 55/F with tuberculosis-related cachexia

74
Q

Which of the following statements is true regarding the properties of the different classes of glucose-lowering agents? (HPIM C397 p2868)
a. SGLT2 inhibitors are more effective than biguanides in lowering HbA1c
b. DPP-IV inhibitors begin to lower the plasma glucose immediately
c. GLP-1 receptor agonists directly cause hypoglycemia
d. Sulfonylureas exhibit longer glycemic control than thiazolidinediones
Feedback

A

CHOICE OF INITIAL GLUCOSE-LOWERING AGENT
Insulin secretagogues, biguanides, GLP-1 receptor agonists, and thiazolidinediones improve glycemic control to a similar degree (1–2% reduction in HbA 1c) and are more effective than a-glucosidase inhibitors, DPP-IV inhibitors, and SGLT2 inhibitors

Assuming a similar degree of glycemic improvement, the clinical advantage of one class of drugs is not clear; any therapy that improves glycemic control is likely beneficial.

Insulin secretagogues, GLP-1 receptor agonists, DPP-IV inhibitors, a-glucosidase inhibitors, and SGLT2 inhibitors begin to lower the plasma glucose immediately, whereas the glucose-lowering effects of the biguanides and thiazolidinediones are delayed by weeks .

Not all agents are effective in all individuals with type 2 DM.

Biguanides, a-glucosidase inhibitors, GLP-1 receptor agonists, DPP-IV inhibitors, thiazolidinediones, and SGLT2 inhibitors do not directly cause hypoglycemia

Most individuals will eventually require treatment with more than one class of oral glucose-lowering agents or insulin, reflecting the progressive nature of type 2 DM

Durability of glycemic control is slightly less for sulfonylureas compared to metformin or thiazolidinediones

The correct answer is: DPP-IV inhibitors begin to lower the plasma glucose immediately

75
Q

A 50/M with T2DM was rushed in the ER due to severe abdominal pain and vomiting. Blood glucose was 300 mg/dL with an arterial pH of 7.2 and a serum bicarbonate of 12 mEq/L. Serum creatine was 250 mmol/L, sodium was 122, chloride was 79 and potassium was 3.0 mEq/L. Which of the following management measures is the most appropriate for the patient’s condition? (HPIM C397 p2871 table 397-8)

a. Administer short-acting regular insulin IV (0.1 units/kg) bolus then 0.1 units/kg/hr by infusion.
b. Give 150 mEqs sodium bicarbonate bolus then give additional 250 mEqs by infusion over 24 hours.
c. Measure electrolytes and anion gap every 4 hours for first 24 hours.
d. Run 2-3 L of 0.45% saline at 10-20 mL/kg/hr over the first 1-3 hours.

A

You cannot give insulin immediately for this patient because his POTASSIUM is only 3 mEq/L; correct potassium first

Despite a bicarbonate deficit, bicarbonate replacement is not usually necessary.

However, in the presence of severe acidosis (arterial pH <7.0), the ADA advises bicarbonate (50 mmol [meq/L] of sodium bicarbonate in 200 mL of sterile water with 10 meq/L KCl per hour for 2 h until the pH is >7.0)

Use 0.9 Saline as the initial fluid for resuscitation, shift to 0.45 saline after volume status has been restored.

The correct answer is: Measure electrolytes and anion gap every 4 hours for first 24 hours.

76
Q

Which of the following laboratory parameters is usually seen following successful treatment of DKA? (HPIM C397 p2872)

a. Decrease in acetoacetate
b. Increase in B-hydroxybutyrate
c. Hypochloremia
d. Normal anion gap metabolic acidosis

A

DKA RESOLUTION
As ketoacidosis improves, b-hydroxybutyrate is converted to acetoacetate. Ketone body levels may appear to increase if measured by laboratory assays that use the nitroprusside reaction, which only detects acetoacetate and acetone

The acidosis and ketosis resolve more slowly than hyperglycemia.

The improvement in acidosis and anion gap, a result of bicarbonate regeneration and decline in ketone bodies, is reflected by a rise in the serum bicarbonate level and the arterial pH

Depending on the rise of serum chloride, the anion gap (but not bicarbonate) will normalize.

A hyperchloremic acidosis (serum bicarbonate of 15–18 mmol/L [15–18 meq/L]) often follows successful treatment and gradually resolves as the kidneys regenerate bicarbonate and excrete chloride

The correct answer is: Normal anion gap metabolic acidosis

77
Q

Which of the following statements best describe hyperglycemic hyperosmolar state (HHS)? (HPIM C397 p2872)

a. HHS has a higher mortality rate than DKA
b. HHS patients are usually younger than DKA patients
c. Fluid losses are less pronounced in HHS compared to in DKA
d. Mental status changes are less seen in HHS compared to in DKA

A

HHS vs. DKA
In HHS, fluid losses and dehydration are usually more pronounced than in DKA due to the longer duration of the illness.

The patient with HHS is usually older, more likely to have mental status changes, and more likely to have a life-threatening precipitating event with accompanying comorbidities

Even with proper treatment, HHS has a substantially higher mortality rate than DKA.

The correct answer is: HHS has a higher mortality rate than DKA
Question 42

78
Q

A 56/M with T2DM was admitted in the ICU due to acute respiratory failure from hospital acquired pneumonia. His CBGs have been ranging from 200 – 300 mg/dL. Which of the following glycemic-lowering agents is most appropriate for him? (HPIM C397 p2873)

a. Insulin glulisine as subcutaneous boluses
b. Regular insulin as intravenous infusion
c. Insulin apidra as intravenous boluses
d. Insulin glargine as single subcutaneous bolus

A

MANAGEMENT OF DM IN A HOSPITALIZED PATIENT
Insulin infusions are preferred in the ICU or in a clinically unstable setting because the half-life of the infused insulin is quite short (minutes)

The absorption of SC insulin may be variable in such situations.

Regular insulin is used rather than insulin analogues for IV insulin infusion because it is less expensive and equally effective.

Insulin-infusion algorithms should integrate the insulin sensitivity of the patient, frequent blood glucose monitoring, and the trend of changes in the blood glucose to determine the insulin-infusion rate.
Because of the short half-life of IV regular insulin, it is necessary to administer long-acting insulin prior to discontinuation of the insulin infusion (2–4 h before the infusion is stopped) to avoid a period of insulin deficiency.

The correct answer is: Regular insulin as intravenous infusion

79
Q

A 42/F with T2DM with a BMI of 30 was admitted in the hospital due to acute pyelonephritis. She is currently afebrile with BP of 120/80. She is currently on insulin glargine 6 units SC injected at night and regular insulin 6 units pre-meals. Her current pre-lunch CBG is 280 mg/dL. Based on ADA recommendations, which of the following regimens will best address her hyperglycemia immediately? (HPIM C397 p2873)

a. Increase insulin glargine to 8 units pre-bedtime
b. Give regular insulin 8 units SC pre-lunch
c. Add insulin glargine 10 units pre-breakfast
d. Give regular insulin 10 units SC pre-lunch

A

MANAGEMENT OF DM IN A HOSPITALIZED PATIENT
In patients who are not critically ill or not in the ICU, basal or “scheduled” insulin is provided by SC, long-acting insulin supplemented by prandial and/or “corrective” insulin using a short-acting insulin (insulin analogues preferred)

The use of “sliding scale,” short-acting insulin alone, where no insulin is given unless the blood glucose is elevated, is inadequate for inpatient glucose management and should not be used.

The short-acting, preprandial insulin dose should include coverage for food consumption (based on anticipated carbohydrate intake) plus a corrective or supplemental insulin based on the patient’s insulin sensitivity and the blood glucose

A corrective insulin supplement might be 1 unit for each 2.7 mmol/L (50 mg/dL) over the glucose target.

If the patient is obese and insulin-resistant, then the insulin supplement might be 2 units for each 2.7 mmol/L (50 mg/dL) over the glucose target (140-180 mg/dL).

For the patient in the case:
• Pre-lunch CBG of 280 mg/dL (100 mg/dL over glucose target of 180 mg/dL)
• For obese patients, we use 2 units for each 50 mg/dL over target
• Since patient is 100 mg/dL over the target (50 x 2) = we add 4 (2 x 2) units to current prelunch regular insulin dose = 6 + 4 = 10 units

The correct answer is: Give regular insulin 10 units SC pre-lunch
Question 44

80
Q

A 28/M with T1DM and choledocholithiasis is about to undergo open cholecystectomy. Which of the following insulin regimens is the LEAST sufficient to address his glycemic control? (HPIM C397 p2874)

a. Regular insulin via insulin pump
b. Regular insulin via IV infusion
c. Regular insulin via multiple SC boluses
d. Insulin detemir via single dose SC

A

MANAGEMENT OF DM IN A HOSPITALIZED PATIENT
Individuals with type 1 DM who are undergoing general anesthesia and surgery or who are seriously ill should receive continuous insulin, either through an IV insulin infusion, their insulin infusion device, or by SC administration of a reduced dose of long-acting insulin.

Short-acting insulin alone is insufficient.

Prolongation of a surgical procedure or delay in the recovery room is not uncommon and may result in periods of insulin deficiency leading to DKA.

Insulin infusion is the preferred method for managing patients with type 1 DM over a prolonged (several hours) perioperative period or when serious concurrent illness is present (0.5–1.0 units/h of regular insulin).

If the diagnostic or surgical procedure is brief (<2 h), a reduced dose of SC insulin may suffice (20–50% basal reduction, with shortacting bolus insulin withheld or reduced).

The correct answer is: Regular insulin via multiple SC boluses

81
Q

According to current recommendations, screening for gestational diabetes mellitus occurs during between what ages of gestation? (HPIM C397 p2874)

a. 12 and 16 weeks
b. 16 and 20 weeks
c. 20 and 24 weeks
d. 24 and 28 weeks

A

GESTATIONAL DM
Current recommendations advise screening for glucose intolerance between weeks 24 and 28 of pregnancy in women not known to have diabetes.

Therapy for GDM is similar to that for individuals with pregnancy-associated diabetes and involves MNT and insulin, if hyperglycemia persists.

Oral glucose-lowering agents are not approved for use during pregnancy, but studies using metformin or glyburide have shown efficacy and have not found toxicity

The correct answer is: 24 and 28 weeks

82
Q

Which of the following statements is consistent with the findings of the DCCT and UKPDS with regards to glycemic control and the development of DM complications? (HPIM C398 p2875-2876)

a. There is strong evidence that chronic hyperglycemia leads to micro- and macrovascular complications.
b. There is a positive impact of a period of improved glycemic control on later disease.
c. The beneficial effects of glycemic control were greater than the beneficial effects of BP control.
d. The benefits of improvement in glycemic control were seen at HbA1c levels ≥ 9%

A

GLYCEMIC CONTROL AND COMPLICATIONS
The microvascular complications of both type 1 and type 2 DM result from chronic hyperglycemia

Evidence implicating a causative role for chronic hyperglycemia in the development of macrovascular complications is less conclusive.

The DCCT phase demonstrated that improvement of glycemic control reduced nonproliferative and proliferative retinopathy (47% reduction), albuminuria (39% reduction), clinical nephropathy (54% reduction), and neuropathy (60% reduction)

The benefits of an improvement in glycemic control occurred over the entire range of HbA1c values, indicating that at any HbA1c level, an improvement in glycemic control is beneficial.

One of the major findings of the UKPDS was that strict blood pressure control significantly reduced both macro- and microvascular complications.

In fact, the beneficial effects of blood pressure control were greater than the beneficial effects of glycemic control.

In both the DCCT and the UKPDS, cardiovascular events were reduced at follow-up of >10 years, even though the improved glycemic control was not maintained

The positive impact of a period of improved glycemic control on later disease has been termed a legacy effect or metabolic memory.

The correct answer is: There is a positive impact of a period of improved glycemic control on later disease.

83
Q

A 70/F with CKD Stage 4 from DM kidney disease came in for her follow-up. She fears that she might also become blind due to her diabetes just like what happened to her father before. Which among her lab findings/characteristics is the strongest predictor for her developing DM retinopathy? (HPIM C398 p2877)

a. Diagnosed DM since 50 years of age
b. Uncontrolled SBP at 150-160 mmHg
c. Urine albumin/crea ratio of 1000 mg/g
d. 1st degree relative with history of DM retinopathy

A

DM RETINOPATHY
Duration of DM and degree of glycemic control are the BEST PREDICTORS of the development of retinopathy.

Nonproliferative retinopathy is found in many individuals who have had DM for >20 years.

Hypertension, nephropathy and dyslipidemia are also risk factors.

Although there is genetic susceptibility for retinopathy, it confers less influence than either duration of DM or degree of glycemic control.

The correct answer is: Diagnosed DM since 50 years of age

84
Q

Which of the following drugs can reduce the progression of diabetic retinopathy? (HPIM C398 p2877)

a. Rosuvastatin
b. Fenofibrate
c. Aspirin
d. Clopidogrel

A

DM RETINOPATHY
Individuals with known retinopathy may be candidates for prophylactic laser photocoagulation when initiating intensive therapy.

Once advanced retinopathy is present, improved glycemic control imparts less benefit, although adequate ophthalmologic care can prevent most blindness.

Fenofibrate, while not reducing cardiovascular events in individuals with diabetes and dyslipidemia, does reduce the progression of retinopathy.

Routine, nondilated eye examinations by the primary care provider or diabetes specialist are inadequate to detect diabetic eye disease, which requires a dilated eye exam performed by an optometrist or ophthalmologist, and subsequent management by a retinal specialist for optimal care of
these disorders.

Treatment of proliferative retinopathy or macular edema with laser photocoagulation and/or anti-VEGF therapy (ocular injection) usually is successful in preserving vision.

Aspirin therapy (650 mg/d) does not appear to influence the natural history of diabetic retinopathy.

The correct answer is: Fenofibrate

85
Q

A 45/M newly diagnosed with T2DM had his 1st positive urinary albumin test. Which of the following is the most appropriate action to take in managing his diabetic nephropathy? (HPIM C398 p2878 fig 398-4)

a. Repeat albuminuria test after 3 months.
b. Repeat albuminuria test after 12 months.
c. Begin treatment of nephropathy immediately.
d. Begin treatment of nephropathy once he has 3 positive albuminuria tests.

A

Since patient has only his 1st positive urine albumin test, next step is to repeat test within 3-6 month period

He needs 2 out of 3 positive urine albumin tests to be diagnosed with albuminuria

Begin treatment only after confirmation of the albuminuria

The correct answer is: Repeat albuminuria test after 3 months.

86
Q

Which of the following measures has the best evidence in reducing urinary albumin excretion and slowing decline in renal function in a 50/F with T2DM and CKD G3bA3? (HPIM C398 p2878-2879)

a. Maintaining HbA1c of ≤ 7.0%
b. Maintaining HbA1c of ≤ 7.5%
c. Maintaining BP <130/80 mmHg
d. Maintaining BP <140/90 mmHg

A

DM NEPHROPATHY
Patient has CKD G3bA3 (Stage 3A with Albuminuria of >300 mg/g) and is at risk for CKD progression.

Improved glycemic control reduces the rate at which albuminuria appears and progresses in type 1 and type 2 DM.

However, once there is a large amount of albuminuria, it is unclear whether improved glycemic control will slow progression of renal disease.

Numerous studies in both type 1 and type 2 DM demonstrate the effectiveness of strict blood pressure control in reducing albumin excretion and slowing the decline in renal function.

Blood pressure should be maintained at <140/90 mmHg in individuals with diabetes and possibly <130/80 in individuals at increased risk for CVD and CKD progression

The correct answer is: Maintaining BP <130/80 mmHg

87
Q

Which of the following statements is true regarding pharmacotherapy for treating DM nephropathy? (HPIM C398 p2879)

a. ACE inhibitors are superior over ARBs in terms of albuminuria reduction.
b. There is no benefit in starting ACE-inhibitors prior to onset of albuminuria.
c. Combination of ACE-inhibitors and ARBs can be used for greater albuminuria reduction.
d. Dihydropyridine CCBs can be used if there are contraindications to ACE-inhibitors or ARBs.

A

DM NEPHROPATHY
Either ACE inhibitors or ARBs should be used to reduce the albuminuria and the associated decline in GFR that accompanies it in individuals with type 1 or type 2 DM.

Most experts believe that the two classes of drugs are equivalent in patient with diabetes.

ARBs can be used as an alternative in patients who develop ACE inhibitor–associated cough or angioedema.

After initiation of therapy, some increase the dose and monitor the urinary albumin.

There is no benefit of intervention prior to onset of albuminuria or using a combination of an ACE inhibitor and an ARB.

If use of either ACE inhibitors or ARBs is not possible or the blood pressure is not controlled, then, diuretics, calcium channel blockers (nondihydropyridine class), or beta blockers should be used.

The correct answer is: There is no benefit in starting ACE-inhibitors prior to onset of albuminuria.

88
Q

Which of the following statements best describe the most common form of diabetic neuropathy? (HPIM C398 p2879)

a. Pain involves the upper extremities, is usually absent at rest and improves at night.
b. There is hyperhidrosis of the upper extremities and anhidrosis of the lower extremities.
c. Involvement of the second cranial nerve is most common and is heralded by diplopia.
d. There is loss of ankle deep-tendon reflexes and foot drop.

A

DM NEUROPATHY
Distal Symmetric Polyneuropathy
• is the most common of diabetic neuropathy
• most frequently presents with distal sensory loss and pain
• Symptoms may include a sensation of numbness, tingling, sharpness, or burning that begins in the feet and spreads proximally
• Pain typically involves the lower extremities, is usually present at rest, and worsens at night.
• As diabetic neuropathy progresses, the pain subsides and eventually disappears, but a sensory deficit persists and motor defects may develop.
• Physical examination often reveals sensory loss (to 10-g monofilament and/or vibration), loss of ankle deep-tendon reflexes, abnormal position sense, and muscular atrophy or foot drop.

Autonomic Neuropathy
• Cardiovascular autonomic neuropathy, reflected by decreased heart rate variability, resting tachycardia and orthostatic hypotension is associated with an increase in CVD
• Gastroparesis and bladder-emptying abnormalities are often caused by the autonomic neuropathy
• Hyperhidrosis of the upper extremities and anhidrosis of the lower extremities

Mononeuropathy
• less common than polyneuropathy in DM and presents with pain and motor weakness in the distribution of a single nerve
• Involvement of the third cranial nerve is most common and is heralded by diplopia.
The correct answer is: There is loss of ankle deep-tendon reflexes and foot drop.

89
Q

Which of the following drugs is FDA-approved for the treatment of diabetic neuropathic pain? (HPIM C398 p2879)

a. Duloxetine
b. Gabapentin
c. Tramadol
d. Venlafaxine

A

DM NEUROPATHY
Chronic, painful diabetic neuropathy is difficultto treat with only symptomatic treatment being available; evidence of the effectiveness of improved glycemic control in painful diabetic neuropathy is lacking.

Two agents, duloxetine and pregabalin, have been approved by the U.S. Food and Drug Administration (FDA) for pain associated with diabetic neuropathy.

Tapentadol, a centrally acting opioid, is also FDA-approved, but has only modest efficacy and poses addiction risk, making it and other opioids less desirable and not a first-line therapy.
Diabetic neuropathy may respond to tricyclic antidepressants, gabapentin, venlafaxine, carbamazepine, tramadol, and topical capsaicin, although none of these are FDA-approved for this indication.

The correct answer is: Duloxetine

90
Q

What is the most common pattern of dyslipidemia seen in diabetes mellitus? (HPIM C398 p2881)

a. High triglyceride, normal HDL, high LDL
b. High triglyceride, low HDL, normal LDL
c. Normal triglyceride, low HDL, high LDL
d. Normal triglyceride, normal HDL, high LDL

A

DYSLIPIDEMIA IN DM
The most common pattern of dyslipidemia is hypertriglyceridemia and reduced high density lipoprotein (HDL) cholesterol levels.

DM itself does not increase levels of low-density lipoprotein (LDL), but the small dense LDL particles found in type 2 DM are more atherogenic because they are more easily glycated and susceptible to oxidation

The correct answer is: High triglyceride, low HDL, normal LDL

91
Q

Which of the following interventions is NOT recommended in the treatment of diabetic foot ulcers or wounds? (HPIM C398 p2882)

a. Off-loading
b. Limited amputation
c. Antiseptic agents
d. Hydrocolloid dressing

A
LOWER EXTREMITY COMPLICATIONS
Interventions with demonstrated efficacy in diabetic foot ulcers or wounds:
•	Off-loading
•	Debridement
•	Wound dressings
•	Appropriate use of antibiotics
•	Revascularization
•	Limited amputation

Antiseptic agents should be avoided. Topical antibiotics are of limited value.

The correct answer is: Antiseptic agents

92
Q

A 33/M known diabetic was rushed into the ER due to 4-day history of fever associated with severe pain, foul-smelling discharge and hearing loss on her right ear. Which of the following organisms is the most common etiologic agent for her condition? (HPIM C398 p2882)

a. Escherichia coli
b. Staphylococcus epidermidis
c. Pseudomonas aeruginosa
d. Staphylococcus aureus

A

INFECTIONS IN DM
Patient has signs and symptoms of invasive otitis externa

Invasive otitis externa is usually secondary to Pseudomonas aeruginosa infection in the soft tissue surrounding the external auditory canal, usually begins with pain and discharge, and may rapidly progress to osteomyelitis and meningitis.

The correct answer is: Pseudomonas aeruginosa

93
Q

Which of the following physiologic responses to hypoglycemia is the primary glucose counterregulatory factor? (HPIM C399 p2884 table 399-2)

a. Decreased insulin
b. Increase glucagon
c. Increased epinephrine
d. Increased cortisol

A

The correct answer is: Increase glucagon

94
Q

Which of the following physiologic responses to hypoglycemia is critical when glucagon levels are deficient? (HPIM C399 p2884 table 399-2)

a. Decreased insulin
b. Increased epinephrine
c. Increased cortisol
d. Development of symptoms

A

The correct answer is: Increased epinephrine

95
Q

A 45/M T2DM patient complained of frequent light headedness, diaphoresis and palpitations. His CBGs ranges from 45-80 mg/dL/ His workup revealed a 1.0 cm pancreatic head mass on abdominal CT scan. Which of the following pathophysiologic features best explain his symptoms in correlation with his disease? (HPIM C399 p2887)

a. Failure of insulin secretion to fall during hypoglycemia
b. Overproduction of an incomplete form of insulin growth factor II
c. Impaired gluconeogenesis and low gluconeogenic precursors
d. Combined deficiency of glucagon and epinephrine

A

HYPOGLYCEMIA WITHOUT DIABETES
Patient most likely has an INSULINOMA.

An insulinoma—an insulin-secreting pancreatic islet b-cell tumor—is the prototypical cause of endogenous hyperinsulinism.

More than 99% of insulinomas are within the substance of the pancreas, and the tumors are usually small (<2.0 cm in diameter in 90% of cases).

The fundamental pathophysiologic feature of endogenous hyperinsulinism caused by a primary b-cell disorder or an insulin secretagogue is the failure of insulin secretion to fall to very low levels during hypoglycemia.

Non-B-cell Tumors: hypoglycemia is due to overproduction of an incompletely processed form of insulin-like growth factor II (“big IGF-II”) that does not complex normally with circulating binding proteins and thus more readily gains access to target tissues.

Iatrogenic hypoglycemia: Combined deficiencies of glucagon and epinephrine in people with insulin-deficient diabetes

Cortisol deficiency: associated with impaired gluconeogenesis and low levels of gluconeogenic precursors
The correct answer is: Failure of insulin secretion to fall during hypoglycemia

96
Q

Which of the lipoprotein particles is the most lipid-rich and least dense? (HPIM C400 p2889)

a. Chylomicrons
b. HDLs
c. LDLs
d. VLDLs

A

LIPOPROTEIN COMPOSITION
Because lipid is less dense than water, the density of a lipoprotein particle is primarily determined by the amount of lipid per particle.

Chylomicrons are the most lipid-rich and therefore least dense lipoprotein particles, whereas HDLs have the least lipid and are therefore the most dense lipoproteins.

In addition to their density, lipoprotein particles can be classified according to their size, determined either by nondenaturing gel electrophoresis or by nuclear magnetic resonance profiling.

There is a strong inverse relationship between density and size, with the largest particles being the most buoyant (chylomicrons) and the smallest particles being the most dense (HDL).

The correct answer is: Chylomicrons

97
Q

A 20/M presents in the ER due to a 2 day-history of severe abdominal pain and vomiting. Pertinent lab findings include a markedly elevated triglyceride level at 1000 mg/dL with slightly elevated LDL and cholesterol levels. Physical exam revealed small, yellowish-white papules on the back. Which of the following conditions does the patient most likely has? (HPIM C400 p2894)

a. Familial Combined Hyperlipidemia
b. Familial Dysbetalipoproteineima
c. Familial Hypercholesterolemia
d. Familial Chylomicronemia

A

PRIMARY HYPERLIPOPROTEINEMIAS

The correct answer is: Familial Chylomicronemia

98
Q

It is important to intervene in patients with fasting triglyceride levels of >500 mg/dL in order to reduce the risk of developing what particular disease? (HPIM C400 p2901)

a. Acute stroke
b. Acute myocardial infarction
c. Acute pancreatitis
d. Acute ischemic hepatitis

A

MANAGEMENT OF SEVERE HYPERTRIGLYCERIDEMIA
It is generally considered appropriate medical practice to intervene in patients with TGs >500 mg/dL in order to reduce the risk of pancreatitis

It remains controversial whether individuals with severe hypertriglyceridemia are at increased risk for ASCVD

Modifying the lifestyle of the patient with severe hypertriglyceridemia often is associated with a significant reduction in plasma TG level.

Despite lifestyle interventions, many patients with severe hypertriglyceridemia require pharmacologic therapy

Patients who persist in having fasting TG >500 mg/dL despite active lifestyle management are candidates for pharmacologic therapy.

The two major classes of drugs used for management of these patients are fibrates and omega-3 fatty acids (fish oils).
The correct answer is: Acute pancreatitis

99
Q

What is the drug of choice for a diabetic 30/F presenting with a triglyceride level of 600 mg/dL despite active lifestyle management? (HPIM C400 p2901)

a. Atorvastatin
b. Cholestyramine
c. Ezetemibe
d. Omega-3 FA

A

MANAGEMENT OF SEVERE HYPERTRIGLYCERIDEMIA
It is generally considered appropriate medical practice to intervene in patients with TGs >500 mg/dL in order to reduce the risk of pancreatitis

It remains controversial whether individuals with severe hypertriglyceridemia are at increased risk for ASCVD

Modifying the lifestyle of the patient with severe hypertriglyceridemia often is associated with a significant reduction in plasma TG level.

Despite lifestyle interventions, many patients with severe hypertriglyceridemia require pharmacologic therapy

Patients who persist in having fasting TG >500 mg/dL despite active lifestyle management are candidates for pharmacologic therapy.

The two major classes of drugs used for management of these patients are fibrates and omega-3 fatty acids (fish oils).

The correct answer is: Omega-3 FA

100
Q

Which of the following statements is true regarding HMG-CoA Reductase Inhibitors? (HPIM C400 p2901-2902)

a. Transaminase elevation of 3x the normal levels in the absence of symptoms does not warrant discontinuation of the drug.
b. They have a modest HDL-raising effect (5-10%) that is generally dose-dependent.
c. Serum CK levels need to be monitored routinely in patients taking these agents to monitor for myopathy.
d. Doubling of the current dose produces a ~15% further reduction in plasma LDL levels.

A

STATINS
The magnitude of LDL lowering associated with statin treatment varies widely among individuals, but once a patient is on a statin, the doubling of the statin dose produces an ~6% further reduction in the level of plasma LDL-C

Statins also reduce plasma TGs in a dose-dependent fashion, which is roughly proportional to their LDL-C–lowering effects

Statins have a modest HDL-raising effect (5–10%) that is not generally dose-dependent.

Serum CK levels need not be monitored on a routine basis in patients taking statins, because an elevated CK in the absence of symptoms does not predict the development of myopathy and does not necessarily suggest the need for discontinuing the drug .

Substantial (greater than three times the upper limit of normal) elevation in transaminases is relatively rare, and mild-to-moderate (one to three times normal) elevation in transaminases in the absence of symptoms need not mandate discontinuing the medication

The correct answer is: Transaminase elevation of 3x the normal levels in the absence of symptoms does not warrant discontinuation of the drug.

101
Q

A hypertensive 45/M has persistently elevated LDL levels despite months of active lifestyle management, maximal doses of rosuvastatin and ezetimibe. What agent can be added to lower his LDL? (HPIM C400 p2902)

a. Colestipol
b. Evolocumab
c. Gemfibrozil
d. Lomitapide

A

PCSK9 INHIBITORS
PCSK9 inhibitors are antibodies that bind to circulating PCSK9 and prevent its interaction with the LDL receptor.

They are highly effective in lowering LDL-C, with a mean 50–60% reduction in LDL-C.

These antibodies are administered subcutaneously every 2–4 weeks.

They are generally well-tolerated, with the major side effect being injection site reactions.

They are indicated as second line (after statin) or third line (after statin + ezetimibe) therapy in patients with FH or CHD in whom LDL-C is not reduced to acceptable levels with statin (+/- ezetimibe) alone.

The correct answer is: Evolocumab

102
Q

Which of the following criteria is included in the Harmonizing Definition Criteria for the metabolic syndrome among South Asian women? (HPIM C401 p2903 table 401-1)

a. Blood pressure <130 mm systolic
b. Waist circumference ≥ 90 cm
c. Fasting triglyceride level >100 mg/dL
d. HDL cholesterol level <40 mg/dL

A

The correct answer is: Blood pressure <130 mm systolic

103
Q

Which of the following is the most important component of weight loss management in metabolic syndrome? (HPIM C401 p2907)

a. Behavior modification
b. Caloric restriction
c. Increased physical activity
d. Pharmacotherapy

A

TREATMENT OF METABOLIC SYNDROME
In general, recommendations for weight loss include a combination of caloric restriction, increased physical activity, and behavior modification.

Caloric restriction is the most important component, whereas increases in physical activity are important for maintenance of weight loss.

The correct answer is: Caloric restriction

104
Q

Which of the following statements best describe the different practices in the management of metabolic syndrome? (HPIM C400 p2907)

a. Low carbohydrate diets are superior to caloric restriction diets in terms of weight reduction after 1 year.
b. Gardening and housecleaning count as physical activities with moderate caloric expenditure.
c. Phentermine is an effective US-FDA approved appetite suppressant for long-term use (>6 months).
d. Bariatric surgery is an option for patients who have a body mass index of >35 kg/m2

A

TREATMENT OF METABOLIC SYNDROME
Diets restricted in carbohydrate typically provide a more rapid initial weight loss.

However, after 1 year, the amount of weight reduction is minimally more reduced or no different from that with caloric restriction alone.

Although increases in physical activity can lead to modest weight reduction, 60–90 min of daily activity is required to achieve this goal.

Even if an overweight or obese adult is unable to undertake this level of activity, a significant health benefit will follow from at least 30 min of moderate-intensity activity daily.

Of note, a variety of routine activities, such as gardening, walking, and housecleaning, require moderate caloric expenditure
The correct answer is: Gardening and housecleaning count as physical activities with moderate caloric expenditure.

105
Q

Which of the following patients with metabolic syndrome will benefit the most from pioglitazone? (HPIM C400 p2909)

a. 32/F with polycystic ovary syndrome
b. 40/M with a BMI of 30
c. 36/M with nephrotic syndrome
d. 41/F with NAFLD

A

TREATMENT OF METABOLIC SYNDROME
Because insulin resistance is the primary pathophysiologic mechanism for the metabolic syndrome, representative drugs in these classes reduce its prevalence.

In a meta-analysis of nine trials involving 12,026 participants, the TZD pioglitazone versus placebo was associated with reduction in ASCVD events in patients with insulin resistance (metabolic syndrome), prediabetes and type 2 diabetes.

Benefit of TZDs has been seen in patients with NAFLD, and with metformin in women with polycystic ovary syndrome, and both drug classes have been shown to reduce markers of inflammation

The correct answer is: 41/F with NAFLD

106
Q

Which of the following is a major inducer of 25-hydroxyvitamin D-1α-hydroxylase? (HPIM C402 p2918)

a. PTH
b. Calcium
c. FGF-23
d. 1,25(OH)2D

A

VITAMIN D SYNTHESIS
In response to ultraviolet radiation of the skin, a photochemical cleavage results in the formation of vitamin D from 7-dehydrocholesterol

Vitamin D enters the circulation whether absorbed from the intestine or synthesized cutaneously, bound
to vitamin D–binding protein, an a-globulin synthesized in the liver

Vitamin D is subsequently 25-hydroxylated in the liver by a cytochrome P450 oxidase in the mitochondria and microsomes.

The second hydroxylation, required for the formation of the mature hormone, occurs in the kidney

The 25-hydroxyvitamin D-1a-hydroxylase is a tightly regulated cytochrome P450–like mixed function oxidase expressed in the proximal convoluted tubule cells of the kidney.

PTH and hypophosphatemia are the major inducers of this microsomal enzyme in the kidney.

Calcium, FGF23, and the enzyme’s product, 1,25(OH)2D, repress it.
The correct answer is: PTH

107
Q

A 60/F was admitted for severe hip and lower back pain after falling from her bed. Physical exam revealed proximal myopathy. Pertinent diagnostic findings include an ionized calcium of 0.7 mmol/L (2.81 mg/dL), serum 25(OH)D of 10 ng/mL and osteopenia and fracture on the pelvic bone. Which of the following findings is expected to be seen on further workup? (HPIM C402 p2920)

a. Normal levels of 1,25(OH)2D
b. Decreased levels of PTH
c. Normal levels of urine calcium
d. Increased levels of phosphorus

A

DIAGNOSIS OF VITAMIN D DEFICIENCY
The most specific screening test for vitamin D deficiency in otherwise healthy individuals is a serum 25(OH)D level.

The National Academy of Medicine has defined vitamin D sufficiency as a vitamin D level >50 nmol/L (>20 ng/mL)

Vitamin D deficiency leads to impaired intestinal absorption of calcium, resulting in decreased serum total and ionized calcium values. This hypocalcemia results in secondary hyperparathyroidism .

In addition to increasing bone resorption, PTH decreases urinary calcium excretion while promoting phosphaturia. This results in hypophosphatemia .

Since PTH is a major stimulus for the renal 25(OH)D 1a-hydroxylase, there is increased synthesis of the active hormone, 1,25(OH)2D.

Paradoxically, levels of this hormone are often normal in severe vitamin D deficiency.

Therefore, measurements of 1,25(OH)2D are not accurate reflections of vitamin D stores and should not be used to diagnose vitamin D deficiency in patients with normal renal function

The correct answer is: Normal levels of 1,25(OH)2D

108
Q

A 45/M consulted due to incidental findings of nephrocalcinosis on ultrasound. He reports no symptoms and further workup revealed elevated intact PTH, serum calcium of 10.5 mg/dL (8.0 – 10.0 mg/dL), creatinine clearance of 70 mL/min. T-score via BMD of lumbar spine was -2.0. Which of his characteristics/findings will be an indication to do surgery for his hyperparathyroidism? (HPIM C403 p2927 table 403-2)

a. Creatinine clearance
b. Nephrocalcinosis
c. Serum calcium
d. T-score

A

The correct answer is: Nephrocalcinosis

109
Q

Which of the following is included in the guidelines for monitoring patients with asymptomatic primary hyperparathyroidism? (HPIM C403 p2927 table 403-3)

a. Serum calcium every 6 months
b. Serum creatinine every 12 months
c. Serum PTH every 12 months
d. Skeletal T-score every 6 months

A

The correct answer is: Serum creatinine every 12 months

110
Q

A 65/M with squamous cell lung CA is seen at the ER lethargic and dyspneic. BP was 140/80 and PE revealed engorged neck veins and diffuse crackles all over. Pertinent lab results showed a serum calcium of 15 mg/dL and creatinine of 450 mmol/L. Which of the following is the best strategy to quickly lower his hypercalcemia? (HPIM C403 p2934-2935 table 403-4)

a. Fast drip with 1L plain saline over 2-3 hours
b. Fast drip with 1L plain saline over 2-3 hours plus furosemide 40 mg IV bolus
c. Start Zolendronate 4 mg IV infusion over 15 minutes
d. Start Calcitonin 200 IU nasal spray, 1 spray per nostril

A

Patient has Hypercalcemia of Malignancy (from Lung CA). His PE indicates that he has pulmonary congestion

Although hydration is the initial choice of treatment for hypercalcemia, it is contraindicated for this patient.

Hydration + forced diuresis is likewise contraindicated

Zolendronate cannot be used due to elevated creatinine.

Calcitonin is the best strategy for rapid correction of hypercalcemia, followed by hemodialysis for this patient.

The correct answer is: Start Calcitonin 200 IU nasal spray, 1 spray per nostril

111
Q

Which of the following conditions causes hypocalcemia due to PTH deficiency? (HPIM C403 p2937 table 403-5)

a. Chronic kidney disease
b. Hypomagnesemia
c. Pseudohypoparathyroidism
d. Tumor lysis syndrome

A

Hypocalcemia associated with hypomagnesemia is associated with both deficient PTH release and impaired responsiveness to the hormone.

Patients with hypocalcemia secondary to hypomagnesemia have absent or low levels of circulating PTH, indicative of diminished
hormone release despite a maximum physiologic stimulus by hypocalcemia.

Plasma PTH levels return to normal with correction of the hypomagnesemia.

Thus hypoparathyroidism with low levels of PTH in blood can be due to hereditary gland failure, acquired gland failure, or acute but reversible gland dysfunction (hypomagnesemia).

The correct answer is: Hypomagnesemia

112
Q

Which of the following is characteristic of the T3 hormone? (HPIM 20th ed. C375 P2695 T375-1)

a. Predominantly formed in the thyroid
b. Higher serum total hormone concentration
c. Longer serum half life
d. Higher metabolic potency

A

The correct answer is: Higher serum total hormone concentration

113
Q

A 30/F came in due to easy fatigability. Thyroid function test done revealed elevated FT4 and low TSH. PE was unremarkable. Radioactive iodine scan revealed low uptake. Which of the following diseases is the LEAST likely cause of this patient’s symptoms? (HPIM 20th ed. C375 P2698)

a. Iodine excess
b. Thyrotoxicosis factitia
c. Ectopic thyroid tissue
d. Graves disease

A

The correct answer is: Graves disease

114
Q

A 65/F consulted due to lethargy with associated weight gain over the past 3 months. On PE, there was bradycardia of 50 bpm. She had periorbital edema, thinning of the hair and bipedal edema. Work up revealed high TSH, normal FT4 and negative TPO antibody. What is the appropriate next step for this patient? (HPIM 20th ed. C376 P2701 F376-2)
a. Annual monitoring
b. LT4 replacement
c. Evaluate anterior pituitary function
d. Check for concomitant drug intake which can cause hypothyroidism
Feedback

A

The correct answer is: LT4 replacement

115
Q

When is symptom relief expected in hypothyroid patients being treated with LT4 replacement? (HPIM 20th ed. C376 P2702)

a. 3-6 months after starting meds
b. 3-6 months after normalization of TSH
c. Immediately after starting meds
d. Immediately after normalization of TSH

A

The correct answer is: 3-6 months after starting meds

116
Q

What is the most appropriate management in a 30/F asymptomatic patient presenting with low TSH, normal FT4, normal FT3? (HPIM 20th ed. C377 P2705 F377-2)

a. Cranial MRI
b. Start LT4 replacement
c. Radionuclide uptake scan
d. Observe and follow-up after 6-12 weeks

A

The correct answer is: Observe and follow-up after 6-12 weeks

117
Q

A 35/F was brought to the ER for generalized tonic clonic seizures. She had a 3-day history of fever with associated cough, diarrhea and vomiting. She had been diagnosed with “goiter” years back, but had not received treatment. PE drowsy patient, showed BP 90/60 mmHg, HR 140s regular, RR 28 and Temp 39ºC. She was anicteric, had a diffusely enlarged anterior neck mass. Chest examination revealed crackles on the right lower lung field. What is the most appropriate initial drug for this case?(HPIM 20th ed. C377 P2707)

a. Methimazole
b. Cholestyramine
c. Propylthiouracil
d. Lithium

A

Management of Thyroid Storm

  • PTU 500-1000 mg LD, then 250 mg q6
  • SSKI 5 drops q6 started 1 hour after PTU is loaded (Wolff-Chaikoff effect)
  • Propranolol 60-80 mg PO q4 or 2 mg IV q4
  • Hydrocortisone 300 mg IV bolus, then 100 mg IV q8
  • Antibiotics if indicated
  • Miscellaneous: cooling, oxygen, IV fluids

The correct answer is: Propylthiouracil

118
Q

Which thyroidal illness presents with a histopathologic picture of patchy inflammatory inflammation with disruption of thyroid follicles, presence of multinucleated giant cells and eventual progression to granuloma formation? (HPIM 20th ed. C377 P2708)

a. Acute thyroiditis
b. de Quervain’s thyroiditis
c. Atrophic thyroiditis
d. Riedel’s thyroiditis

A

The correct answer is: de Quervain’s thyroiditis

119
Q

In the revised guidelines for staging thyroid cancers (particularly for papillary and follicular), what is the new age cut-off in the criteria? (HPIM 20th ed. C378 P2714)

a. 40 years old
b. 45 years old
c. 50 years old
d. 55 years old

A

The correct answer is: 55 years old

120
Q

A 40/F consulted for a palpable anterior neck mass that has increased in size in the past 2 months, with associated hoarseness and dysphagia. Ultrasound of the mass showed features of malignancy. FNAB showed cells with large, clear nuclei with powdery chromatin with nuclear grooves and prominent nucleoli. What is the most likely diagnosis? (HPIM 20th ed. C378 P2715)

a. Papillary
b. Follicular
c. Anaplastic
d. Medullary

A

The correct answer is: Papillary

121
Q

A patient consulted for a palpable nodule on the anterior neck. Initial history, PE and tests pointed towards a non-functioning nodule. Thyroid UTZ confirmed the presence of a thyroid nodule. FNAB showed follicular cells of undetermined significance. Which of the following is the appropriate next step for this patient? (HPIM 20th ed. C378 P2718 F378-4)

a. Observe and repeat UTZ after 6 months
b. Repeat UTZ-guided FNAB
c. Thyroidectomy
d. RAI

A

The correct answer is: Repeat UTZ-guided FNAB

122
Q

What is the most common hormone involved in hypercalcemia of malignancy of solid tumors? (HPIM 20th ed. C403 P2930)

a. PTH
b. PTHrP
c. Vitamin D
d. Calcitonin

A

Hypercalcemia of Malignancy
PTHrP
• most common substance involved in solid tumors (humoral hypercalcemia of malignancy)
• Usually associated with squamous cell CA and renal tumors
• Causes bone resorption through systemic action
Direct bone marrow invasion
• Usually in hematologic malignancies
• Bone resorption through local destruction
Increased 1,25(OH)2D
• Usually seen in lymphoma

The correct answer is: PTHrP

123
Q

A 75/M was recently diagnosed with lung cancer. He complained of constipation and bone pains. Tests done revealed calcium of 4mg/dL. What is the initial management? (HPIM 20th ed. C403 P2935)

a. IV hydration
b. Bisphosphonates
c. Calcitonin
d. Dialysis

A

The correct answer is: IV hydration

124
Q

Which of the following patients would require bone mineral density testing? (HPIM 20th ed. C404 P2948 T404-4)

a. A 60/F who came in for an executive check up
b. A 45/M who sustained a fracture on his radius after falling from a lower branch of guava tree
c. A 25/F recently diagnosed SLE patient taking prednisone 5mg for 1 month
d. A 50/M who has a heavy smoking and alcohol history

A
Risk factors include:
•	Prior fracture
•	Family history of hip fracture
•	Low body weight
•	Cigarette smoking
•	Excessive alcohol use
•	Steroid use
•	Rheumatoid arthritis

The correct answer is: A 60/F who came in for an executive check up

125
Q

What is the recommended amount for adequate daily calcium intake in a pregnant 25-year-old? (HPIM 20th ed. C404 P2951 T404-7)

a. 800 mg/day
b. 1000 mg/day
c. 1200 mg/day
d. 1300 mg/day

A

The correct answer is: 1000 mg/day

126
Q

A 25/F presented with amenorrhea. On investigation, she was also noted to have central adiposity, proximal myopathy and purplish abdominal striae. Initial tests showed midnight plasma cortisol of 150 nmol/L (elevated). Further testing showed ACTH is 4 pg/ml (low). Which of the following is the most likely diagnosis? (HPIM 20th ed. C379 P2724 T379-1)

a. Adrenal adenoma
b. Pituitary adenoma
c. Pancreatic carcinoids
d. Small cell lung cancer

A

The correct answer is: Pituitary adenoma

127
Q

Which of the following is characteristic of T3 compared to T4? (HPIM 20th ed. C375 P2695 T375-1)

a. Predominantly formed in the thyroid
b. Higher serum total hormone concentration
c. Longer serum half life
d. Higher metabolic potency

A

The correct answer is: Higher metabolic potency

128
Q

65/F consulted in the OPD due to lethargy with associated weight gain over the past 3 months. On PE, vital signs were normal except for bradycardia at 50 bpm. She had periorbital edema, thinning of the hair and bipedal edema. Work up revealed high TSH, normal FT4 and negative TPO antibody. What is the appropriate next step for this patient? (HPIM 20th ed. C376 P2701 F376-2)

a. Annual monitoring
b. LT4 replacement
c. Evaluate anterior pituitary function
d. Check for concomitant drug intake that can cause hypothyroid state

A

The correct answer is: LT4 replacement

129
Q

. In the revised guidelines for staging thyroid cancers (particularly for papillary and follicular), what is the new age cut-off in the criteria? (HPIM 20th ed. C378 P2714)

a. 40 years old
b. 45 years old
c. 50 years old
d. 55 years old

A

The correct answer is: 55 years old

130
Q

A 75/M was recently diagnosed with lung cancer. He complained of constipation and bone pains. Labs were done revealing calcium of 4mg/dL. What is the initial management? (HPIM 20th ed. C403 P2935)

a. IV hydration
b. Bisphosphonates
c. Calcitonin
d. Dialysis

A

The correct answer is: Bisphosphonates

131
Q

Which is true of the thyroid axis regulation? (pp 2692 – 2693)

a. Reduced thyroid hormone levels decrease basal TSH production.
b. High thyroid hormone levels enhance TRH stimulation of TSH.
c. Thyroid hormones act via negative feedback through thyroid hormone receptor β2 (TRβ2).
d. The “set-point” in this axis is established by TRH.

A

The correct answer is: Thyroid hormones act via negative feedback through thyroid hormone receptor β2 (TRβ2).

132
Q

Which true of factors that alter thyroid function in pregnancy? (p 2694)

a. Rise in TSH that persists into the middle of pregnancy.
b. Estrogen-induced decrease in TBG during the first trimester.
c. Increased thyroid hormone metabolism by the placenta.
d. Decreased urinary iodide excretion.

A

The correct answer is: Increased thyroid hormone metabolism by the placenta.

133
Q

Which is true regarding Tg measurement in the follow-up of thyroid cancer patients? (recall, pp 2697 – 2698)

a. Levels are elevated after total thyroidectomy
b. Levels are undetectable after radioablation.
c. Undetectable levels indicate recurrent cancer.
d. Undetectable levels indicate incomplete ablation.

A

The correct answer is: Levels are undetectable after radioablation.

134
Q

Which pathologic feature is more consistent with Hashimoto’s thyroiditis than atrophic thyroiditis? (p 2699)

a. Extensive fibrosis.
b. Less pronounced lymphocyte infiltration.
c. Almost completely absent thyroid follicles.
d. Absence of colloid.

A

The correct answer is: Absence of colloid.

135
Q

Which is the correct dose adjustment vis-à-vis clinical use of levothyroxine? (compre pp 2701 – 2702)

a. 150μg per day – hypothyroidism post Graves’ disease treatment
b. 25 – 50μg per day – subclinical hypothyroidism requiring treatment
c. 50 – 75μg per day – elderly patient with coronary artery disease
d. At least 50% increase in daily dose – pregnant patient

A

The correct answer is: 25 – 50μg per day – subclinical hypothyroidism requiring treatment

136
Q

A pregnant patient on her 2nd month of pregnancy is referred for the co-management of her Graves’ disease. Her goiter is small and she is biochemically euthyroid on methimazole 5mg/day. What would be your plan for the patient? ( p 2707)

a. Discontinue her methimazole and monitor her thyroid function.
b. Continued therapy is necessary and shift her methimazole to PTU.
c. PTU would be needed for the duration of pregnancy.
d. Antithyroid are always needed in the last trimester of pregnancy

A

The correct answer is: Discontinue her methimazole and monitor her thyroid function.

137
Q

A patient with Graves’ disease presents with fever, delirium and seizures, diarrhea and jaundice. This was preceded by 3 days history of fever and productive cough and discontinuation of antithyroid drugs due to poor oral intake. What is not part of the initial emergent management needed for the patient? (p 2707)

a. Large dose of PTU given via nasogastric tube or per rectum (500 – 1000mg loading dose then 250mg every 4 hours).
b. 5 drops of SSKI together with loading dose of antithyroid drug then every 6 hours.
c. β-blocker preferably high dose Propranolol PO every 4 hours.
d. Antibiotics for the community acquired pneumonia.

A

The correct answer is: 5 drops of SSKI together with loading dose of antithyroid drug then every 6 hours.

138
Q

Which of the following patients would require bone mineral density testing? (HPIM 20th ed. C404 P2948 T404-4)
a. A 60/F who came in for an executive check up
b. A 45/M who sustained a fracture on his radius after falling from a lower branch of guava tree
c. A 25/F recently diagnosed SLE patient taking prednisone 5mg for 1 month
d. A 50/M who has a heavy smoking and alcohol history
Feedback

A
Risk factors include:
•	Prior fracture
•	Family history of hip fracture
•	Low body weight
•	Cigarette smoking
•	Excessive alcohol use
•	Steroid use
•	Rheumatoid arthritis

The correct answer is: A 60/F who came in for an executive check up

139
Q

Which of the following statements regarding the use of DXA for the evaluation of osteoporosis is TRUE?

a. A Z-score of -1 means that the patient’s bone density is 1 standard deviation lower than the average for a young population that is matched for race and sex.
b. Bone spurs falsely decrease bone density of the spine.
c. Osteoporosis is classically defined as a T-score of < 2.5 in the lumbar spine, femoral neck, or wrist.
d. Small slim people tend to have lower than average BMD measurements.

A

The correct answer is: Small slim people tend to have lower than average BMD measurements.

140
Q

Which of the following statements regarding treatment for the metabolic syndrome is TRUE?

a. Bariatric surgery in an option in patients with metabolic syndrome and a BMI of > 40 kg/m2, or 35 kg/m2 with comorbidities.
b. Orlistat is classified as an appetite suppressant that reduces the incidence of type 2 diabetes.
c. Restriction of ~1000-kcal daily is expected to result in weight reduction of 1 lb. per week.
d. Statins are the drug of choice to lower fasting triglyceride levels.

A

The correct answer is: Bariatric surgery in an option in patients with metabolic syndrome and a BMI of > 40 kg/m2, or 35 kg/m2 with comorbidities.

141
Q

A 38/F came into your clinic concerned about having diabetes. She has a strong family history of the disease and her father progressed to dialysis-requiring renal failure due to DM. Her BMI is 28 kg/m2. She was otherwise asymptomatic and physical examination was unremarkable. When is it appropriate to screen diabetes and repeat the test if results are normal? (UNITE CPG)

a. Now then every year thereafter
b. Now then every three years
c. Age 40 then every year thereafter
d. Age 40 then every three years

A

The correct answer is: Now then every year thereafter

142
Q

A 24/F G3P2 (2002) consulted due to concerns of having gestational diabetes mellitus. She denied having GDM for her prior pregnancies and all her babies were delivered full term and size appropriate for gestational age. Her mother has type 1 diabetes mellitus. Her pre-pregnancy BMI was 23 kg/m2. Labs done showed FBS 80 mg/dL and urinalysis was positive for mild albuminuria. Which of her characteristics would predispose her to have GDM? (UNITE CPG)

a. Age
b. Family history of type 1 diabetes mellitus
c. FBS 80 mg/dL
d. Albuminuria

A

The correct answer is: Family history of type 1 diabetes mellitus

143
Q

A 35/M was previously diagnosed by his primary care physician with diabetes 5 years ago. He was initially started on insulin but was eventually shifted to metformin once his sugar was controlled. On PE, his BMI is 20 kg/m2 and does not exhibit acanthosis nigricans. He, however, complains of alopecia. CBG taken was 350 mg/dl but stat ketones were negative. On work-up, islet antibodies were positive. What is the most likely diagnosis for this patient? (HPIM 20th ed. C396 P2859)

a. Ketosis-prone type 2 diabetes mellitus
b. Latent autoimmune diabetes of the adult
c. Maturity-onset diabetes of the young
d. Fulminant diabetes

A

The correct answer is: Latent autoimmune diabetes of the adult

144
Q

A 50/M was just diagnosed with type 2 diabetes mellitus. Which of the following is an appropriate treatment goal for the patient? (HPIM 20th ed. C397 P2860 T397-2)

a. HbA1c <7.5%
b. Triglyceride < 150 mg/dL
c. LDL < 70 mg/dL
d. BP < 140/90

A

The correct answer is: BP < 140/90

145
Q

Which of the following long acting insulins has the longest effective duration? (HPIM 20th ed. C397 P2863 T397-4)

a. Degludec
b. Detemir
c. Glargine
d. NPH

A

The correct answer is: Degludec

146
Q

A 60/F patient on an unrecalled oral diabetes medication consulted in your clinic due to recurrent UTI. What is the most likely OHA that the patient is taking? (HPIM 20th ed. C397 P2866 T397-5)

a. Acarbose
b. Canagliflozin
c. Pioglitazone
d. Sitagliptin

A

The correct answer is: Canagliflozin

147
Q

A 23/M diagnosed with Type I diabetes mellitus presented with diabetic ketoacidosis. He was started on IV hydration and subsequently initiated on insulin drip. His latest CBG was 350 mg/dL. Latest ABG revealed pH 7.3 PCO2 29, HCO3 12. What is the next step in the management? (HPIM 20th ed.C396 P2871)

a. Shift IVF to D5-containing
b. Give bicarbonate bolus
c. Continue insulin drip titration
d. Start long acting subcutaneous insulin

A

The correct answer is: Continue insulin drip titration

148
Q

Which of the following management strategies is appropriate for patients with diabetic kidney disease? (HPIM 20th ed. C398 P2878-9)

a. ACE/ARBs should be used only if blood pressure is elevated
b. Protein intake should be at least 1mg/kg body weight due to the catabolic state of such patients
c. BP should be maintained to less than 130/80 if the patient is at risk for CKD progression
d. Strict glycemic control has been shown to slow progression of renal disease despite the presence of large amounts of albuminuria

A

The correct answer is: BP should be maintained to less than 130/80 if the patient is at risk for CKD progression

149
Q

A 50-year old diabetic male presented in the OPD with a non-healing wound on his left foot. Which of the following interventions have been shown to be effective in such patients? (HPIM 20th ed. C398 P2882)

a. Radical amputation
b. Wound exposure to promote drying
c. Topical antibiotics
d. Revascularization

A

The correct answer is: Revascularization

150
Q

What is the body’s first line of defense against hypoglycemia? (HPIM 20th ed. C399 P2884 T399-2)

a. Increase glucagon
b. Increase epinephrine
c. Decrease insulin
d. Decrease cortisol

A

The correct answer is: Decrease insulin

151
Q

Which of the following is characteristic of T3 compared to T4? (HPIM 20th ed. C375 P2695 T375-1)

a. Predominantly formed in the thyroid
b. Higher serum total hormone concentration
c. Longer serum half life
d. Higher metabolic potency

A

The correct answer is: Higher metabolic potency

152
Q

A 30/F came in due to easy fatigability. TFTs done revealed elevated FT4 and low TSH. PE was unremarkable. Subsequent radioactive iodine scan revealed low uptake. Which of the following diseases is the LEAST likely cause of this patient’s symptoms? (HPIM 20th ed. C375 P2698)

a. Iodine excess
b. Thyrotoxicosis factitia
c. Ectopic thyroid tissue
d. Graves disease

A

The correct answer is: Graves disease

153
Q

A 65/F consulted in the OPD due to lethargy with associated weight gain over the past 3 months. On PE, vital signs were normal except for bradycardia at 50 bpm. She had periorbital edema, thinning of the hair and bipedal edema. Work up revealed high TSH, normal FT4 and negative TPO antibody. What is the appropriate next step for this patient? (HPIM 20th ed. C376 P2701 F376-2)

a. Annual monitoring
b. LT4 replacement
c. Evaluate anterior pituitary function
d. Check for concomitant drug intake which can cause hypothyroidism

A

The correct answer is: LT4 replacement

154
Q

When is symptom relief expected in hypothyroid patients being treated with LT4 replacement? (HPIM 20th ed. C376 P2702)

a. 3-6 months after starting meds
b. 3-6 months after normalization of TSH
c. Immediately after starting meds
d. Immediately after normalization of TSH

A

The correct answer is: 3-6 months after normalization of TSH

155
Q

What is the most appropriate management in a 30/F asymptomatic patient presenting with low TSH, normal FT4, normal FT3? (HPIM 20th ed. C377 P2705 F377-2)
a. Cranial MRI
b. Start LT4 replacement
c. Radionuclide uptake scan
d. Observe and follow-up after 6-12 weeks
Feedback

A

The correct answer is: Observe and follow-up after 6-12 weeks

156
Q

A 35/F was brought into the ER for seizures. She presented with a 3-day history of fever with associated cough, diarrhea and vomiting. She eventually had GTCs prompting consult. PE showed BP 90/60, HR 140s regular, RR 28 and Temp 39 dec C. She was anicteric, with note of a palpable, diffusely enlarged anterior neck mass. Chest examination revealed crackles on the right lower lung field. Given this presentation, what is the antithyroid of choice to be given to this patient? (HPIM 20th ed. C377 P2707)

a. Methimazole
b. Cholestyramine
c. Propylthiouracil
d. Lithium

A

The correct answer is: Propylthiouracil

157
Q

Which thyroidal illness will present with a histopathologic picture of patchy inflammatory inflammation with disruption of thyroid follicles, presence of multinucleated giant cells and eventual progression to granuloma formation? (HPIM 20th ed. C377 P2708)

a. Acute thyroiditis
b. de Quervain’s thyroiditis
c. Atrophic thyroiditis
d. Riedel’s thyroiditis

A

The correct answer is: de Quervain’s thyroiditis

158
Q

In the revised guidelines for staging thyroid cancers (particularly for papillary and follicular), what is the new age cut-off in the criteria? (HPIM 20th ed. C378 P2714)

a. 40 years old
b. 45 years old
c. 50 years old
d. 55 years old

A

The correct answer is: 55 years old

159
Q

A 40/F consulted for a palpable anterior neck mass. It had been growing over the past 2 months with associated hoarseness and dysphagia. Ultrasound of the mass is suspicious for malignancy. FNAB showed cells with large, clear nuclei with powdery chromatin with nuclear grooves and prominent nucleoli. What is the most likely diagnosis? (HPIM 20th ed. C378 P2715)

a. Papillary
b. Follicular
c. Anaplastic
d. Medullary

A

The correct answer is: Papillary

160
Q

A patient consulted for a palpable nodule on the anterior neck. Initial history, PE and labs pointed towards a non-functioning nodule. Thyroid UTZ confirmed the presence of a thyroid nodule. FNAB was done which showed follicular lesion of undetermined significance. Which of the following is the appropriate next step for this patient? (HPIM 20th ed. C378 P2718 F378-4)

a. Observe and repeat UTZ after 6 months
b. Repeat UTZ-guided FNAB
c. Thyroidectomy
d. RAI

A

The correct answer is: Repeat UTZ-guided FNAB

161
Q

What is the most common substance involved in hypercalcemia of malignancy of solid tumors? (HPIM 20th ed. C403 P2930)

a. PTH
b. PTHrP
c. Vitamin D
d. Calcitonin

A

The correct answer is: PTHrP

162
Q

A 75/M was recently diagnosed with lung cancer. He complained of constipation and bone pains. Labs were done revealing calcium of 4mg/dL. What is the initial management? (HPIM 20th ed. C403 P2935)

a. IV hydration
b. Bisphosphonates
c. Calcitonin
d. Dialysis

A

The correct answer is: Bisphosphonates

163
Q

Which of the following patients would require bone mineral density testing? (HPIM 20th ed. C404 P2948 T404-4)

a. A 60/F who came in for an executive check up
b. A 45/M who sustained a fracture on his radius after falling on an outstretched arm
c. A 25/F recently diagnosed SLE patient taking prednisone 5mg for 1 month
d. A 60/M who has a heavy smoking and alcohol history

A

The correct answer is: A 60/M who has a heavy smoking and alcohol history

164
Q

What is the recommended amount for adequate daily calcium intake in a pregnant 25-year-old? (HPIM 20th ed. C404 P2951 T404-7)

a. 800 mg/day
b. 1000 mg/day
c. 1200 mg/day
d. 1300 mg/day

A

The correct answer is: 1000 mg/day

165
Q

A 25/F presented with amenorrhea. On investigation, she was also noted to have central adiposity, proximal myopathy and purplish abdominal striae. Initial labs showed midnight plasma cortisol of 150 nmol/L (elevated). Further testing showed ACTH is 4 pg/ml (low). Which of the following is the most likely diagnosis? (HPIM 20th ed. C379 P2724 T379-1)

a. Adrenal adenoma
b. Pituitary adenoma
c. Pancreatic carcinoids
d. Small cell lung cancer

A

The correct answer is: Adrenal adenoma

166
Q

A 45/M came in due to uncontrolled hypertension. He is currently on 3 antihypertensive medications and a diuretic. On probing, you note that he frequently has palpitations, headache and profuse sweating. Which of the following laboratory tests is consistent with the likely diagnosis? (HPIM 20th ed. C380 P2740 T380-1)

a. Anemia
b. Hyponatremia
c. Hyperglycemia
d. Hypocalcemia

A

The correct answer is: Hyperglycemia

167
Q

A 30/F who recently gave birth at home was brought to the ER for decrease in sensorium. She initially complained of severe headache and gradually became more somnolent. On arrival, it was noted that she as hypotensive and CBG was low. STAT cranial CT revealed an intracranial hemorrhage. What is the most likely diagnosis? (HPIM 20th ed. C372 P2665)

a. Pituitary apoplexy
b. Meningitis
c. Intracranial tumor
d. Lymphocytic hypophysitis

A

The correct answer is: Pituitary apoplexy

168
Q

A 30/F came in due to inability to conceive. History also revealed amenorrhea. She has been experiencing milk let down for the past 2 months despite not having given birth. No other symptoms were noted. PE was unremarkable, with no note of neurologic or ophthalmologic deficits. Serum PRL level was 150 ug/L. MRI revealed a sellar mass, measuring 8mm in largest diameter. Desirous of pregnancy, what is the best treatment for this patient? (HPIM 20th ed. C273 P2676)

a. Observation
b. Bromocriptine
c. Cabergoline
d. Surgical resection

A

The correct answer is: Bromocriptine

169
Q

A 30/M consulted urinary frequency. Past medical history was unremarkable. Initial work up revealed 24-hour urine volume and urine osmolarity of 50ml/kg and osmolarity of 200 mosm/L. Following the algorithm on the approach to patients with suspected diabetes insipidus, what is the next step in the work up of this patient? (HPIM 20th ed. C374 P2687 F374-4)

a. Basal plasma AVP
b. Brain MRI
c. Fluid deprivation test
d. Trial of desmopressin therapy

A

The correct answer is: Basal plasma AVP

170
Q

Which of the following patients can be diagnosed with metabolic syndrome based on the NCEP:ATP III 2001 definition?

a. A 40/M with waist circumference of 105 cm, TG of 140 mg/dL and BP of 130/80
b. A 45/F with diagnosed diabetic on a statin with BP of 120/80
c. A 45/F with HDL of 40 mg/dL, BP of 120/90 and waist circumference of 90cm
d. A 30/F on metformin for PCOS and enalapril for hypertension

A

The correct answer is: A 45/F with HDL of 40 mg/dL, BP of 120/90 and waist circumference of 90cm

171
Q

A 68/M diagnosed case of squamous cell lung CA is seen at the ER drowsy with rapid and deep breathing. Pertinent lab results showed a serum calcium of 15 mg/dL and creatinine of 450 mmol/L. Which of the following is the best strategy to quickly lower his hypercalcemia?

a. Fast drip with 1L plain saline over 2-3 hours
b. Fast drip with 1L plain saline over 2-3 hours plus furosemide 40 mg IV bolus
c. Start Zolendronate 4 mg IV infusion over 15 minutes
d. Start Calcitonin 200 IU nasal spray, 1 spray per nostril

A

The correct answer is: Start Calcitonin 200 IU nasal spray, 1 spray per nostril

172
Q

What is the recommended frequency of monitoring patients with asymptomatic hyperparathyroidism?

a. Serum calcium every 6 months
b. Serum creatinine every 12 months
c. Serum PTH every 12 months
d. Skeletal T-score every 6 months

A

The correct answer is: Serum creatinine every 12 months

173
Q

Among weight loss regimen for metabolic syndrome, which is the most important component?

a. Lifestyle change
b. Low calorie diet
c. Increased physical activity
d. Maintenance metformin

A

The correct answer is: Low calorie diet

174
Q

What is the most important complication/outcome of patients with uncontrolled fasting triglyceride levels of >500 mg/dL?

a. Acute stroke
b. Acute myocardial infarction
c. Acute pancreatitis
d. Acute ischemic hepatitis

A

The correct answer is: Acute pancreatitis

175
Q

Which of the following statements best corresponds to peripheral neuropathy in diabetes?

a. Pain in the legs are precipitated by walking and relieved by rest.
b. Bell’s palsy is common in diabetic polyneuropathy
c. Involvement of the third cranial nerve is most common and is heralded by diplopia.
d. Loss of ankle deep-tendon reflexes and foot drop.

A

The correct answer is: Loss of ankle deep-tendon reflexes and foot drop.

176
Q

Which of the following measures has the best evidence in reducing urinary albumin excretion and slowing decline in renal function in a 50/F with T2DM and CKD G3bA3?

a. Maintaining HbA1c of ≤ 7.0%
b. Maintaining HbA1c of ≤ 7.5%
c. Maintaining BP <130/80 mmHg
d. Maintaining BP <140/90 mmHg

A

The correct answer is: Maintaining BP <130/80 mmHg